Perioperative blood transfusion and blood conservation in cardiac surgery: the Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists clinical practice guideline.

[1]  O. Isom,et al.  A clinical evaluation of three modern blood oxygenators , 1987 .

[2]  G. Sfakianakis,et al.  Platelet preservation during cardiopulmonary bypass with iloprost and Duraflo-II heparin-coated surfaces. , 1991, ASAIO Transactions.

[3]  R. E. Clark,et al.  Redo cardiac surgery: late bleeding complications from topical thrombin-induced factor V deficiency. , 1993, The Journal of thoracic and cardiovascular surgery.

[4]  L. Griffith,et al.  A prospective study to identify the risk factors associated with acute reactions to platelet and red cell transfusions , 1993, Transfusion.

[5]  I. Palacios,et al.  Continuous quality improvement decreases length of stay and adverse events: a case study in an interventional cardiology program. , 1997, American Journal of Managed Care.

[6]  E. Topol,et al.  Comparison of bivalirudin versus heparin during percutaneous coronary intervention (the Randomized Evaluation of PCI Linking Angiomax to Reduced Clinical Events [REPLACE]-1 trial). , 2004, The American journal of cardiology.

[7]  J. Fareed,et al.  New Anticoagulants for the Cardiovascular Patient , 1995 .

[8]  R. Lewisohn.  Blood transfusion: 50 years ago and today. , 1955, Surgery, gynecology & obstetrics.

[9]  A. Goldman,et al.  Recombinant factor VII for severe bleeding during extracorporeal membrane oxygenation following open heart surgery , 2005, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[10]  D. Massel,et al.  Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors. , 1990, The Journal of clinical investigation.

[11]  J. Fontcuberta,et al.  Aprotinin versus desmopressin for patients undergoing operations with cardiopulmonary bypass. A double-blind placebo-controlled study. , 1995, The Journal of thoracic and cardiovascular surgery.

[12]  A E Voytovich,et al.  Transfusion errors in New York State: an analysis of 10 years' experience , 2000, Transfusion.

[13]  H. Gale,et al.  Open-heart surgery in von Willebrand's disease. , 1975, The Journal of thoracic and cardiovascular surgery.

[14]  R. Delfino,et al.  [Comparison between low and high doses of aprotinin in heart surgery]. , 1994, Minerva Anestesiologica.

[15]  W. Catalona,et al.  A prospective randomized comparison of three blood conservation strategies for radical prostatectomy. , 1999, Anesthesiology.

[16]  A. Kulier,et al.  Subcutaneous recombinant human erythropoietin and autologous blood donation before coronary artery bypass surgery. , 1993, Anesthesia and analgesia.

[17]  V. Sonzogni,et al.  Erythropoietin therapy and preoperative autologous blood donation in children undergoing open heart surgery. , 2001, British journal of anaesthesia.

[18]  S. Marsch,et al.  A randomized comparison of clopidogrel and aspirin versus ticlopidine and aspirin after the placement of coronary artery stents. , 2003, Journal of the American College of Cardiology.

[19]  D. Jobes,et al.  Increased accuracy and precision of heparin and protamine dosing reduces blood loss and transfusion in patients undergoing primary cardiac operations. , 1995, The Journal of thoracic and cardiovascular surgery.

[20]  J. Amiral,et al.  Immunization by bovine thrombin used with fibrin glue during cardiovascular operations. Development of thrombin and factor V inhibitors. , 1993, Journal of Thoracic and Cardiovascular Surgery.

[21]  S. Ferraris,et al.  Operative outcome and hospital cost. , 1998, The Journal of thoracic and cardiovascular surgery.

[22]  S. Clark,et al.  Effect of low molecular weight heparin (fragmin) on bleeding after cardiac surgery. , 2000, The Annals of thoracic surgery.

[23]  A. Dalmasso,et al.  Prospective, randomized trial of autotransfusion after routine cardiac operations. , 1993, The Annals of thoracic surgery.

[24]  J. Paramo,et al.  Randomized Study of Aprotinin and DDAVP to Reduce Postoperative Bleeding After Cardiopulmonary Bypass Surgery , 1994, Circulation.

[25]  S. Ziemer,et al.  A Practical Concept for Preoperative Management of Patients With Impaired Primary Hemostasis , 2004, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[26]  M. Eisses,et al.  Strategies to reduce hemostatic activation during cardiopulmonary bypass. , 2006, Thrombosis research.

[27]  R. A. Krouscoup.  Nursing interventions to decrease bleeding at the femoral access site after percutaneous coronary intervention. , 2000, American Journal of Critical Care.

[28]  P. McCarthy,et al.  Hemostatic profiles of HeartMate ventricular assist device recipients. , 1995, ASAIO journal.

[29]  S. A. Wilson,et al.  Disorders of motility and muscle tone with special reference to the corpus striatum , 1925 .

[30]  J. Wennberg,et al.  Multivariate Prediction of In‐Hospital Mortality Associated With Coronary Artery Bypass Graft Surgery , 1992 .

[31]  G. Angelini,et al.  In-hospital patients exposed to clopidogrel before coronary artery bypass graft surgery: a word of caution. , 2005, The Annals of thoracic surgery.

[32]  G. Silvay,et al.  Profound anemia following cardiac surgery. , 1993, Journal of Cardiothoracic and Vascular Anesthesia.

[33]  M. Pasic,et al.  Risk and benefit of low systemic heparinization during open heart operations. , 1994, The Annals of thoracic surgery.

[34]  M. Pfisterer,et al.  Effects of low-dose aspirin (50-mg/day), low-dose aspirin plus dipyridamole, and oral anticoagulant agents after internal mammary artery bypass-grafting: Patency and clinical outcome at 1 year , 1994 .

[35]  Vivek Trikha,et al.  Clinical Study , 1961, Acta neurologica Scandinavica.

[36]  R. Habib,et al.  Adverse effects of low hematocrit during cardiopulmonary bypass in the adult: should current practice be changed? , 2003, The Journal of thoracic and cardiovascular surgery.

[37]  I. Jovin,et al.  Post-operative course of coronary artery bypass surgery patients who pre-donate autologous blood. , 2003, International journal of cardiology.

[38]  H Kusagawa,et al.  Clinical experience with Nikkiso centrifugal pumps for extracorporeal circulation. , 1994, Artificial organs.

[39]  W. Browner,et al.  Practice pattern variability for myocardial revascularization: impact on resource use across 24 centers. , 2002, Journal of cardiothoracic and vascular anesthesia.

[40]  R. Wunderink,et al.  Effect of clopidogrel on bleeding after coronary artery bypass surgery , 2001, Critical care medicine.

[41]  P. Mortensen,et al.  Autotransfusion after coronary artery bypass grafting halves the number of patients needing blood transfusion. , 1996, The Annals of thoracic surgery.

[42]  Irwin Gratz,et al.  Polymerized bovine hemoglobin solution as a replacement for allogeneic red blood cell transfusion after cardiac surgery: results of a randomized, double-blind trial. , 2002, The Journal of thoracic and cardiovascular surgery.

[43]  J. Chesebro.  Effect of dipyridamole and aspirin on vein graft patency after coronary bypass operations. , 1990, Thrombosis research. Supplement.

[44]  O. Dale,et al.  Prophylactic Treatment with Desmopressin Does Not Reduce Postoperative Bleeding After Coronary Surgery in Patients Treated with Aspirin Before Surgery , 2004, Anesthesia and analgesia.

[45]  P. Tesar,et al.  Late complications of tissue glues in aortic surgery. , 2000, The Annals of thoracic surgery.

[46]  R. Hongo,et al.  The effect of clopidogrel in combination with aspirin when given before coronary artery bypass grafting. , 2002, Journal of the American College of Cardiology.

[47]  I. Iakovou,et al.  Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. , 2005, JAMA.

[48]  Russell L. Stogsdill,et al.  A regional intervention to improve the hospital mortality associated with coronary artery bypass graft surgery. The Northern New England Cardiovascular Disease Study Group. , 1996, JAMA.

[49]  J. W. Bland,et al.  Successful Use of a Reduced Dose of Protamine After Cardiopulmonary Bypass , 1976, Anesthesia and analgesia.

[50]  M. Jessen,et al.  Aprotinin But Not &egr;-Aminocaproic Acid Decreases Interleukin-10 After Cardiac Surgery With Extracorporeal Circulation: Randomized, Double-Blind, Placebo-Controlled Study in Patients Receiving Aprotinin and &egr;-Aminocaproic Acid , 2001, Circulation.

[51]  R. Caterina,et al.  Bleeding Time and Bleeding: An Analysis of the Relationship of the Bleeding Time Test With Parameters of Surgical Bleeding , 1994 .

[52]  G. Horowitz,et al.  Reducing adult phlebotomy blood loss with the use of pediatric-sized blood collection tubes. , 1989, American journal of clinical pathology.

[53]  S. Body,et al.  Variability in Transfusion Practice for Coronary Artery Bypass Surgery Persists Despite National Consensus Guidelines: A 24‐Institution Study , 1998 .

[54]  S. Yusuf,et al.  Effects of Aspirin Dose When Used Alone or in Combination With Clopidogrel in Patients With Acute Coronary Syndromes: Observations From the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) Study , 2003, Circulation.

[55]  S. Ferraris,et al.  Limiting excessive postoperative blood transfusion after cardiac procedures. A review. , 1995, Texas Heart Institute journal.

[56]  E. Cohen,et al.  Emergency Coronary Artery Bypass Surgery in the Era of Glycoprotein IIb/IIIa Receptor Antagonist Use , 2001, Journal of cardiac surgery.

[57]  W. Gahl,et al.  Successful bilateral lung transplantation for pulmonary fibrosis associated with the Hermansky-Pudlak syndrome. , 2005, The Journal of Heart and Lung Transplantation.

[58]  D. Hunter,et al.  First, gather the data. , 2006, The New England journal of medicine.

[59]  R. E. Clark,et al.  A multicenter, double-blind, placebo-controlled trial of aprotinin for reducing blood loss and the requirement for donor-blood transfusion in patients undergoing repeat coronary artery bypass grafting. , 1995, Circulation.

[60]  L. Menicanti,et al.  Beneficial effects of Duraflo II heparin-coated circuits on postperfusion lung dysfunction. , 1996, The Annals of thoracic surgery.

[61]  R. Elkins,et al.  Aortic root replacement with pulmonary autograft. , 1989, Circulation.

[62]  T. Karlsson,et al.  Neurological and general outcome in low-risk coronary artery bypass patients using heparin coated circuits. , 2001, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[63]  G. Hempelmann,et al.  Influence of acute preoperative plasmapheresis on platelet function in cardiac surgery. , 1993, Journal of cardiothoracic and vascular anesthesia.

[64]  R. White,et al.  Does intraoperative hetastarch administration increase blood loss and transfusion requirements after cardiac surgery , 2000 .

[65]  B. Medalion,et al.  Preoperative use of enoxaparin is not a risk factor for postoperative bleeding after coronary artery bypass surgery. , 2003, Journal of Thoracic and Cardiovascular Surgery.

[66]  Germing,et al.  High Pressure Coronary Stenting: Efficacy and Safety of Aspirin Versus Coumadin Plus Aspirin Ñ Preliminary Results of a Randomized Study. , 1997, The Journal of invasive cardiology.

[67]  B. Lytle,et al.  Transfusion increases the risk of postoperative infection after cardiovascular surgery. , 2006, Journal of the American College of Surgeons.

[68]  P. Biglioli,et al.  The Effect of Multiple Blood Conservation Techniques on Donor Blood Exposures in Adult Coronary and Valve Surgery Performed with a Membrane Oxygenator: A Multivariate Analysis on 1310 Patients. , 1995, Journal of cardiac surgery.

[69]  J. Gold,et al.  Comprehensive multimodality blood conservation: 100 consecutive CABG operations without transfusion. , 1998, The Annals of thoracic surgery.

[70]  D. V. Van Riper,et al.  Hemostatic Effects of Tranexamic Acid and Desmopressin During Cardiac Surgery , 1991, Circulation.

[71]  J. Hardy,et al.  Pharmacological strategies for blood conservation in cardiac surgery: erythropoietin and antifibrinolytics. , 2001, Canadian Journal of Anaesthesia-journal Canadien D Anesthesie.

[72]  K. Dalva,et al.  Effects of combined conventional and modified ultrafiltration in adult patients. , 2001, The Annals of thoracic surgery.

[73]  S. Body,et al.  Safety and efficacy of shed mediastinal blood transfusion after cardiac surgery: A multicenter observational study , 1999 .

[74]  W. Nugent,et al.  Playing by the numbers: how collecting outcomes data changed by life. , 1994, Annals of Thoracic Surgery.

[75]  B. Spiess,et al.  Transfusion of Blood Products Affects Outcome in Cardiac Surgery , 2004, Seminars in cardiothoracic and vascular anesthesia.

[76]  R. Weiskopf.  Efficacy of Acute Normovolemic Hemodilution Assessed as a Function of Fraction of Blood Volume Lost , 2001, Anesthesiology.

[77]  T. DeMarco,et al.  Use of bivalirudin, a direct thrombin inhibitor, and its reversal with modified ultrafiltration during heart transplantation in a patient with heparin-induced thrombocytopenia. , 2005, The Journal of Heart and Lung Transplantation.

[78]  P. McCarthy,et al.  A prospective randomized trial of Duraflo II heparin-coated circuits in cardiac reoperations. , 1999, Annals of Thoracic Surgery.

[79]  W. van Oeveren,et al.  Aprotinin reduces intraoperative and postoperative blood loss in membrane oxygenator cardiopulmonary bypass. , 1991, The Annals of thoracic surgery.

[80]  J. van der Linden,et al.  Aprotinin Decreases Postoperative Bleeding and Number of Transfusions in Patients on Clopidogrel Undergoing Coronary Artery Bypass Graft Surgery: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial , 2005, Circulation.

[81]  S. Pocock,et al.  Vascular complications associated with arteriotomy closure devices in patients undergoing percutaneous coronary procedures: a meta-analysis. , 2004, Journal of the American College of Cardiology.

[82]  L. Eysman,et al.  Reduced platelet activation and improved hemostasis after controlled cardiotomy suction during clinical membrane oxygenator perfusions. , 1985, The Journal of thoracic and cardiovascular surgery.

[83]  R. Körfer,et al.  Alpha-2 plasmin inhibitor-plasmin complex and postoperative blood loss: double-blind study with aprotinin in reoperation for myocardial revascularization. , 1993, The Journal of thoracic and cardiovascular surgery.

[84]  O. Alfieri,et al.  Hemostatic effects of aprotinin, tranexamic acid and epsilon-aminocaproic acid in primary cardiac surgery. , 1999, The Annals of thoracic surgery.

[85]  C. Borchgrevink,et al.  The Duke and Ivy Methods for Determination of the Bleeding Time , 1963, Thrombosis and Haemostasis.

[86]  C. Sudlow,et al.  Thienopyridines or aspirin to prevent stroke and other serious vascular events in patients at high risk of vascular disease? A systematic review of the evidence from randomized trials. , 2000, Stroke.

[87]  L. Eijsman,et al.  Hemostatic efficacy of dipyridamole, tranexamic acid, and aprotinin in coronary bypass grafting. , 1995, The Annals of thoracic surgery.

[88]  T. Treasure,et al.  Pre-operative aspirin decreases platelet aggregation and increases post-operative blood loss--a prospective, randomised, placebo controlled, double-blind clinical trial in 100 patients with chronic stable angina. , 1994, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[89]  J. J. Morris,et al.  Autotransfusion: is there a benefit in a current practice of aggressive blood conservation? , 1994, The Annals of thoracic surgery.

[90]  G. Despotis,et al.  Monitoring hirudin anticoagulation in two patients undergoing cardiac surgery with a plasma-modified act method. , 2002, Anesthesiology.

[91]  L. Goodnough,et al.  Establishing practice guidelines for surgical blood management. , 1995, American journal of surgery.

[92]  J L Cox,et al.  Reexploration for bleeding is a risk factor for adverse outcomes after cardiac operations. , 1996, The Journal of thoracic and cardiovascular surgery.

[93]  G. Hicks,et al.  Leukocyte-reduced transfusions in cardiac surgery results of an implementation trial. , 2002, American journal of clinical pathology.

[94]  G. Nuttall,et al.  Comparison of Blood-conservation Strategies in Cardiac Surgery Patients at High Risk for Bleeding , 2000, Anesthesiology.

[95]  B. Jarvis,et al.  Clopidogrel , 2000, Drugs.

[96]  B. Toth,et al.  A clinical evaluation of a blood conservation device in medical intensive care unit patients , 1993, Critical care medicine.

[97]  P. Loewen,et al.  The efficacy and safety of combination warfarin and ASA therapy: a systematic review of the literature and update of guidelines. , 1998, Canadian Journal of Cardiology.

[98]  Stanley,et al.  Overview of randomized trials of intravenous heparin in patients with acute myocardial infarction treated with thrombolytic therapy. , 1996, The American journal of cardiology.

[99]  K. M. Taylor,et al.  EFFECT OF APROTININ ON NEED FOR BLOOD TRANSFUSION AFTER REPEAT OPEN-HEART SURGERY , 1987, The Lancet.

[100]  H. Sievers,et al.  Reduction of homologous blood requirements by blood-pooling at the onset of cardiopulmonary bypass. , 1994, The Journal of thoracic and cardiovascular surgery.

[101]  L. Eckel,et al.  Emergency Coronary Artery Bypass Grafting: Does Excessive Preoperative Anticoagulation Increase Bleeding Complications and Transfusion Requirements? , 2001, Cardiovascular surgery.

[102]  R. Dewall,et al.  Membrane vs bubble oxygenators: a prospective study of 52 patients. , 1979, Archives of surgery.

[103]  W. Vaughn,et al.  Blood use in patients undergoing repeat coronary artery bypass graft procedures: multivariate analysis , 1995, Transfusion.

[104]  G. Tsonis,et al.  Does leukodepletion during elective cardiac surgery really influence the overall clinical outcome? , 2003, The Journal of cardiovascular surgery.

[105]  B. Walpoth,et al.  Effects of Unprocessed and Processed Cardiopulmonary Bypass Blood Retransfused into Patients after Cardiac Surgery , 1999, The International journal of artificial organs.

[106]  H. Weisman,et al.  New Antiplatelet Agents: Platelet GPIIb/llla Antagonists , 1995, Thrombosis and Haemostasis.

[107]  H. Ohuchi,et al.  [Aprotinin and recombinant human erythropoietin reduce the need for homologous blood transfusion in cardiac surgery]. , 1998, The Japanese Journal of Thoracic and Cardiovascular Surgery.

[108]  M. Goldberg.  Perioperative epoetin alfa increases red blood cell mass and reduces exposure to transfusions: results of randomized clinical trials. , 1997, Seminars in hematology.

[109]  D. Grobbee,et al.  Early Outcome After Off-Pump Versus On-Pump Coronary Bypass Surgery: Results From a Randomized Study , 2001, Circulation.

[110]  A. Lindahl,et al.  The anticoagulant effect in heparinized blood and plasma resulting from interactions with extrinsic pathway inhibitor. , 1991, Thrombosis research.

[111]  J. Richardson,et al.  Diagnosis and management of malignant pleural effusions. , 1995, American journal of surgery.

[112]  K. Kawazoe,et al.  Effective use of fibrin glue for acute aortic dissection. , 2005, The Annals of thoracic surgery.

[113]  P. Cabrales,et al.  Microvascular perfusion upon exchange transfusion with stored red blood cells in normovolemic anemic conditions , 2004, Transfusion.

[114]  R. Mohr,et al.  The hemostatic effect of transfusing fresh whole blood versus platelet concentrates after cardiac operations. , 1988, The Journal of thoracic and cardiovascular surgery.

[115]  X. Moreau,et al.  Comparaison des effets de l’aprotinine et de l’acide tranexamique sur le saignement en chirurgie cardiaque , 1995 .

[116]  D. Reich,et al.  Heparin and protamine titration do not improve haemostasis in cardiac surgical patients , 1998, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[117]  R. Cornudella,et al.  [Comparative study of 2 antithrombotic regimens in 75 patients with coronary endoprostheses]. , 1997, Sangre.

[118]  D. Messinger,et al.  Avoidance of allogeneic blood transfusions by treatment with epoetin beta (recombinant human erythropoietin) in patients undergoing open-heart surgery , 1997 .

[119]  M. Yoda,et al.  [Safety and efficacy of autologous blood donation before elective off-pump coronary artery bypass grafting]. , 2004, Kyobu geka. The Japanese journal of thoracic surgery.

[120]  H. Bricard,et al.  Efficacité respective du Cell Saver ® et de la récupération du circuit de CEC ultrafiltré en chirurgie cardiaque , 1991 .

[121]  A. Gonzalez,et al.  Hemodilution and surgical hemostasis contribute significantly to transfusion requirements in patients undergoing coronary artery bypass. , 2005, The Journal of thoracic and cardiovascular surgery.

[122]  K. Yasuda,et al.  Cardiac surgery for a patient with familial lecithin: cholesterol acyltransferase deficiency. , 2005, The Japanese Journal of Thoracic and Cardiovascular Surgery.

[123]  Patrick Royston,et al.  Generic, Simple Risk Stratification Model for Heart Valve Surgery , 2005, Circulation.

[124]  W. Weintraub,et al.  Off-pump coronary artery bypass grafting provides complete revascularization with reduced myocardial injury, transfusion requirements, and length of stay: a prospective randomized comparison of two hundred unselected patients undergoing off-pump versus conventional coronary artery bypass grafting. , 2003, The Journal of thoracic and cardiovascular surgery.

[125]  Z. Straka,et al.  Use of recombinant activated factor VII in cardiac surgery for an effective treatment of severe intractable bleeding. , 2004, Japanese heart journal.

[126]  E. Fosse,et al.  Reduced complement activation with heparin-coated oxygenator and tubings in coronary bypass operations. , 1992, The Journal of thoracic and cardiovascular surgery.

[127]  K. Sanger,et al.  Superiority of centrifugal pump over roller pump in paediatric cardiac surgery: prospective randomised trial. , 1998, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[128]  H. McDonnell.  Enhancing the use of clinical guidelines: a social norms perspective. , 2006, Journal of the American College of Surgeons.

[129]  M. Newman,et al.  Intraoperative physiologic variables and outcome in cardiac surgery: Part I. In-hospital mortality. , 2000, Annals of Thoracic Surgery.

[130]  D. Cumberland,et al.  Pharmacologic prevention of acute ischemic complications of coronary angioplasty. , 1997, Catheterization and Cardiovascular Diagnosis.

[131]  F. Loop,et al.  Autotransfusion following cardiac operations: a randomized, prospective study. , 1979, The Annals of thoracic surgery.

[132]  M. A. O'Brien,et al.  Nursing interventions to decrease bleeding at the femoral access site after percutaneous coronary intervention. SANDBAG Nursing Coordinators. Standards of Angioplasty Nursing Techniques to Diminish Bleeding Around the Groin. , 1999, American Journal of Critical Care.

[133]  G. Gravlee,et al.  SAFE LIMITS OF ISOVOLEMIC HEMODILUTION AND RECOMMENDATIONS FOR ERYTHROCYTE TRANSFUSION , 1990, International anesthesiology clinics.

[134]  E. Greco,et al.  Heparin-coated circuit in coronary surgery. A clinical study. , 1996, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[135]  H. Billett,et al.  The preoperative bleeding time as a predictor of postoperative hemorrhage after cardiopulmonary bypass. , 1986, The Journal of thoracic and cardiovascular surgery.

[136]  F. Carmichael.  Recent developments in hemoglobin-based oxygen carriers--an update on clinical trials. , 2001, Transfusion and Apheresis Science.

[137]  R. Shemin,et al.  Technique for routine use of heparin bonded circuits with a reduced anticoagulation protocol. , 2000, The journal of extra-corporeal technology.

[138]  L. Goodnough,et al.  Monitoring of hemostasis in cardiac surgical patients: impact of point-of-care testing on blood loss and transfusion outcomes. , 1997, Clinical chemistry.

[139]  Chan Kh,et al.  Acute normovolemic hemodilution in coronary artery bypass graft surgery. , 1991 .

[140]  M. Bozdayi,et al.  Influence of Two Blood Conservation Techniques (Cardiotomy Reservoir Versus Cell‐Saver) on Biocompatibility of the Heparin Coated Cardiopulmonary Bypass Circuit During Coronary Revascularization Surgery , 1997, Journal of cardiac surgery.

[141]  M. Mathru,et al.  Cardiovascular adjustments and gas exchange during extreme hemodilution in humans , 1991, Critical Care Medicine.

[142]  R. Califf,et al.  Immediate and reversible platelet inhibition after intravenous administration of a peptide glycoprotein IIb/IIIa inhibitor during percutaneous coronary intervention. , 1995, American Journal of Cardiology.

[143]  V. Videm,et al.  Extracorporeal membrane oxygenation using a centrifugal pump and a servo regulator to prevent negative inlet pressure. , 1997, Annals of Thoracic Surgery.

[144]  L. Goodnough,et al.  Future directions in utilization review: the role of transfusion algorithms. , 1998, Transfusion science.

[145]  E. Inada.  Blood coagulation and autologous blood transfusion in cardiac surgery. , 1990, Journal of clinical anesthesia.

[146]  G. Sanz,et al.  Prevention of early aortocoronary bypass occlusion by low-dose aspirin and dipyridamole. Grupo Español para el Seguimiento del Injerto Coronario (GESIC) , 1990, Circulation.

[147]  Thomas E. Moritz,et al.  Improvement in early saphenous vein graft patency after coronary artery bypass surgery with antiplatelet therapy: results of a Veterans Administration Cooperative Study. , 1988, Circulation.

[148]  J. Ray,et al.  Increased blood product use among coronary artery bypass patients prescribed preoperative aspirin and clopidogrel , 2003, BMC cardiovascular disorders.

[149]  W. Williams,et al.  Effect of heparin loading during congenital heart operation on thrombin generation and blood loss. , 1997, The Annals of thoracic surgery.

[150]  J. Remadi,et al.  Prospective randomized study comparing coronary artery bypass grafting with the new mini-extracorporeal circulation Jostra System or with a standard cardiopulmonary bypass. , 2006, American heart journal.

[151]  Piotr Jarosik,et al.  The use of recombinant coagulation factor VIIa in uncontrolled postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass* , 2004, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[152]  A. Kuitunen,et al.  Cardiopulmonary bypass with heparin-coated circuits and reduced systemic anticoagulation. , 1997, The Annals of thoracic surgery.

[153]  J. Freyssinet,et al.  Anti-thrombin activities of heparin. Effect of saccharide chain length on thrombin inhibition by heparin cofactor II and by antithrombin. , 1989, The Biochemical journal.

[154]  B. Horne,et al.  Preoperative Use of Enoxaparin Compared With Unfractionated Heparin Increases the Incidence of Re-Exploration for Postoperative Bleeding After Open-Heart Surgery in Patients Who Present With an Acute Coronary Syndrome: Clinical Investigation and Reports , 2002, Circulation.

[155]  O. Alfieri,et al.  Hemostatic effects of aprotinin, tranexamic acid and ϵ-aminocaproic acid in primary cardiac surgery , 1999 .

[156]  Y. Okita,et al.  Is use of aprotinin safe with deep hypothermic circulatory arrest in aortic surgery? Investigations on blood coagulation. , 1996, Circulation.

[157]  Patricia Langenberg,et al.  Meta-Analysis, Decision Analysis, and Cost Effectiveness Analysis: Methods for Quantitative Synthesis in Medicine, 2nd Edition , 2000 .

[158]  T. Monk.  Preoperative recombinant human erythropoietin in anemic surgical patients , 2004, Critical care.

[159]  R. Yozu,et al.  Efficiency of an Air Filter at the Drainage Site in a Closed Circuit with a Centrifugal Blood Pump: An In Vitro Study , 2001, ASAIO journal (1992).

[160]  R. Means,et al.  Clinical application of recombinant erythropoietin in the anemia of chronic disease. , 1994, Hematology/Oncology Clinics of North America.

[161]  A. Siegbahn,et al.  No benefit of reduced heparinization in thoracic aortic operation with heparin-coated bypass circuits. , 2000, The Annals of thoracic surgery.

[162]  M. Rand,et al.  Platelet function in autoimmune (idiopathic) thrombocytopenic purpura , 1998, Acta paediatrica.

[163]  D. Mangano.  Aspirin and mortality from coronary bypass surgery. , 2002, The New England journal of medicine.

[164]  W. van Oeveren,et al.  Systemic blood activation during and after autotransfusion. , 1994, The Annals of thoracic surgery.

[165]  J. Verska.  Control of heparinization by activated clotting time during bypass with improved postoperative hemostasis. , 1977, The Annals of thoracic surgery.

[166]  H. Roskamm,et al.  A randomized comparison of clopidogrel and aspirin versus ticlopidine and aspirin after the placement of coronary-artery stents. , 2000, Circulation.

[167]  R. Vasudevan,et al.  Coronary artery bypass grafting in immune thrombocytopenic purpura. , 1997, The Annals of thoracic surgery.

[168]  R. Warters,et al.  Clopidogrel and platelet transfusion in patients undergoing coronary artery bypass graft surgery * , 2003, Anaesthesia.

[169]  H. Krumholz.  Organization to Assess Strategies for Ischemic Syndromes (OASIS). , 1997 .

[170]  R. Shemin,et al.  Effect of anticoagulation protocol on outcome in patients undergoing CABG with heparin-bonded cardiopulmonary bypass circuits. , 1998, The Annals of thoracic surgery.

[171]  B. Pasche,et al.  The platelet function defect of cardiopulmonary bypass. , 1993, Blood.

[172]  Ulf Abdel-Rahman,et al.  Initial experience with a minimized extracorporeal bypass system: is there a clinical benefit? , 2005, The Annals of thoracic surgery.

[173]  B. Birmingham.  TEE diagnosis of mechanical AVR dysfunction associated with biological glue. , 2001, Anesthesia and Analgesia.

[174]  J. Pepper,et al.  Tissue Factor Is Rapidly Elevated in Plasma Collected from the Pericardial Cavity during Cardiopulmonary Bypass , 2000, Thrombosis and Haemostasis.

[175]  S. Chauhan,et al.  Heparin Dosing and Postoperative Blood Loss in Patients Taking Aspirin , 1998 .

[176]  A. Sturk,et al.  Low-dose and high-dose aprotinin improve hemostasis in coronary operations. , 1996, The Journal of thoracic and cardiovascular surgery.

[177]  S. Pothula,et al.  The Effect of Preoperative Antiplatelet/Anticoagulant Prophylaxis on Postoperative Blood Loss in Cardiac Surgery , 2004, Anesthesia and Analgesia.

[178]  O. Alfieri,et al.  Surgical Management of Left Ventricular Free Wall Rupture after Acute Myocardial Infarction , 1995, Cardiovascular surgery.

[179]  M. Metzdorff,et al.  Emergency coronary artery bypass graft surgery in abciximab-treated patients. , 2000, The Annals of thoracic surgery.

[180]  J. Fisher.  Pharmacologic modulation of erythropoietin production. , 1988, Annual review of pharmacology and toxicology.

[181]  C. Hogue,et al.  On the need for improved transfusion indicators in cardiac surgery. , 1995, The Annals of thoracic surgery.

[182]  M. Blombäck,et al.  Hemostatic disturbances associated with implantation of an artificial heart. , 1987, Thrombosis Research.

[183]  L. Jaques,et al.  A train difference in anticoagulant response to subcutaneous administration of heparin in mice. , 1978, Thrombosis research.

[184]  C. Hogue,et al.  Factors Associated with Excessive Postoperative Blood Loss and Hemostatic Transfusion Requirements: A Multivariate Analysis in Cardiac Surgical Patients , 1996, Anesthesia and analgesia.

[185]  G. Palatianos,et al.  Clinical effectiveness of leukocyte filtration during cardiopulmonary bypass in patients with chronic obstructive pulmonary disease. , 2004, The Annals of thoracic surgery.

[186]  H. Aoki,et al.  Mitral valve replacement in a patient with idiopathic thrombocytopenic purpura. , 2000, The Japanese journal of thoracic and cardiovascular surgery : official publication of the Japanese Association for Thoracic Surgery = Nihon Kyobu Geka Gakkai zasshi.

[187]  A. Mattioli,et al.  Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients , 2002, BMJ : British Medical Journal.

[188]  Matthew H Samore,et al.  Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project. , 2006, Journal of the American College of Cardiology.

[189]  David Blumenthalt,et al.  Improving clinical practice : total quality management and the physician , 1996 .

[190]  R. Mentzer,et al.  Aspirin and Postoperative Bleeding After Coronary Artery Bypass Grafting , 2002, Annals of surgery.

[191]  J. Magovern,et al.  A model for predicting transfusion after coronary artery bypass grafting. , 1996, The Annals of thoracic surgery.

[192]  Paul M Ness,et al.  Universal leukoreduction decreases the incidence of febrile nonhemolytic transfusion reactions to RBCs , 2004, Transfusion.

[193]  H. Krumholz,et al.  Blood transfusion in elderly patients with acute myocardial infarction. , 2001, The New England journal of medicine.

[194]  D. Paparella,et al.  The effects of high-dose heparin on inflammatory and coagulation parameters following cardiopulmonary bypass , 2005, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[195]  R. Berger,et al.  Comparative evaluation of a new disposable rotating membrane oxygenator with bubble oxygenator. , 1976, The Annals of thoracic surgery.

[196]  M. Yada,et al.  [Preoperative autologous blood donation in patients undergoing open heart surgery]. , 2003, Kyobu geka. The Japanese journal of thoracic surgery.

[197]  J. Boldt,et al.  The influence of allogeneic red blood cell transfusion compared with 100% oxygen ventilation on systemic oxygen transport and skeletal muscle oxygen tension after cardiac surgery. , 2004, Anesthesia and analgesia.

[198]  Richa Km,et al.  Mitral valve replacement in a patient with idiopathic thrombocytopenic purpura: preoperative treatment with danazol. , 1991, Journal of Cardiovascular Surgery.

[199]  N. Smedira,et al.  Assessment of hemostatic activation during cardiopulmonary bypass for coronary artery bypass grafting with bivalirudin: results of a pilot study. , 2005, The Journal of thoracic and cardiovascular surgery.

[200]  E. L. Wallace,et al.  Red cell transfusions in coronary artery bypass surgery (DRGs 106 and 107) , 1992, Transfusion.

[201]  A. Liebold,et al.  Four years' experience with a miniaturized extracorporeal circulation system and its influence on clinical outcome. , 2004, Artificial organs.

[202]  J. Egan,et al.  Recombinant activated factor VII in paediatric cardiac surgery , 2004, Intensive Care Medicine.

[203]  J. V. van Lanschot,et al.  Profound hemodilution: what is the critical level of hemodilution at which oxygen delivery-dependent oxygen consumption starts in an anesthetized human? , 1992, Anesthesia and analgesia.

[204]  R. Schall,et al.  High-dose Aprotinin in Cardiac Surgery—A Prospective, Randomized Study , 1994, Anaesthesia and intensive care.

[205]  J. Hirsh,et al.  Heparin Binding Proteins Contribution to Heparin Rebound After Cardiopulmonary Bypass , 1993, Circulation.

[206]  A. Schwartz,et al.  Monitoring heparin anticoagulation and its neutralization. , 1981, The Annals of thoracic surgery.

[207]  R. Bellomo,et al.  Hemofiltration during Cardiopulmonary Bypass for High Risk Adult Cardiac Surgery , 2003, International Journal of Artificial Organs.

[208]  H. Thaler,et al.  Reinfusion of mediastinal blood after heart surgery. , 2000, The Journal of thoracic and cardiovascular surgery.

[209]  J. Utley.  Pathophysiology of Cardiopulmonary Bypass: Current Issues , 1990, Journal of cardiac surgery.

[210]  R. Califf,et al.  Starting aspirin therapy after operation. , 1992, Circulation.

[211]  J. Avorn,et al.  Multivariate predictors of blood product use in cardiac surgery. , 2003, Journal of cardiothoracic and vascular anesthesia.

[212]  H. Scheld,et al.  Are patients with Werlhof's disease at increased risk for bleeding complications when undergoing cardiac surgery? , 2000, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[213]  M. Hynynen,et al.  Hemodynamic responses to desmopressin acetate after CABG: a double-blind trial. , 1991, Journal of Cardiothoracic and Vascular Anesthesia.

[214]  G. Engström,et al.  Fat contamination of pericardial suction blood and its influence on in vitro capillary-pore flow properties in patients undergoing routine coronary artery bypass grafting. , 2002, The Journal of thoracic and cardiovascular surgery.

[215]  M. Crowther,et al.  Direct thrombin inhibitors. , 2002, Thrombosis research.

[216]  J. Ansell,et al.  Does desmopressin acetate prophylaxis reduce blood loss after valvular heart operations? A randomized, double-blind study. , 1992, The Journal of thoracic and cardiovascular surgery.

[217]  B. Spiess,et al.  Argatroban for off-pump coronary artery bypass surgery. , 2003, Anesthesia and Analgesia.

[218]  J. Keeler,et al.  Protamine—the need to determine the dose , 1991, Anaesthesia.

[219]  I. Christlieb,et al.  Cell saver efficacy for routine coronary artery bypass surgery , 1996, Perfusion.

[220]  S. Lemeshow,et al.  Blood conservation for myocardial revascularization. Is it cost effective? , 1987, The Journal of thoracic and cardiovascular surgery.

[221]  T. Abe,et al.  Cardiac surgery using only autologous blood for a patient with hereditary spherocytosis: a case report. , 1998, Annals of Thoracic and Cardiovascular Surgery.

[222]  D. Lublin,et al.  Off-label use of recombinant factor VIIA concentrates after cardiac surgery. , 2005, The Annals of thoracic surgery.

[223]  N. Tabuchi,et al.  Activation of fibrinolysis in the pericardial cavity during cardiopulmonary bypass , 1993 .

[224]  Andrew D. Rosenberg,et al.  Practice Guidelines for Blood Component Therapy: A Report by the American Society of Anesthesiologists Task Force on Blood Component Therapy , 1996, Anesthesiology.

[225]  M. Turina,et al.  [R-hirudin (lepirudin, refludan) as an alternative anticoagulant in heparin-induced thrombocytopenia during cardiopulmonary bypass connection]. , 2000, Swiss medical weekly.

[226]  F. Loop,et al.  Influence of oxygenator type on the prevalence and extent of microembolic retinal ischemia during cardiopulmonary bypass. Assessment by digital image analysis. , 1990, The Journal of thoracic and cardiovascular surgery.

[227]  V. Vainionpää,et al.  Leukocyte filtration improves brain protection after a prolonged period of hypothermic circulatory arrest: A study in a chronic porcine model. , 2000, The Journal of thoracic and cardiovascular surgery.

[228]  A. Schmermund,et al.  Systematic use of a collagen‐based vascular closure device immediately after cardiac catheterization procedures in 1,317 consecutive patients , 2002, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[229]  F. Loop,et al.  Aprotinin therapy for reoperative myocardial revascularization: a placebo-controlled study. , 1992, The Annals of thoracic surgery.

[230]  P. Raven,et al.  Intraoperative treatment strategy to reduce the incidence of postcardiopulmonary bypass atrial fibrillation , 2002, Perfusion.

[231]  J. Rumberger,et al.  Aprotinin for coronary artery bypass grafting: effect on postoperative renal function. , 1995, The Annals of thoracic surgery.

[232]  H. Scheld,et al.  Effect of platelet inhibitors on thromboembolism after implantation of a Novacor N100--preliminary results. , 1998, The Thoracic and cardiovascular surgeon.

[233]  B. Seifert,et al.  Perioperative course and recovery after heparin-coated cardiopulmonary bypass: low-dose versus high-dose heparin management. , 1996, Journal of cardiothoracic and vascular anesthesia.

[234]  D. Loisance,et al.  [Aprotinin in cardiac surgery in patients with platelet anti-aggregant treatment]. , 1993, Archives des maladies du coeur et des vaisseaux.

[235]  M. Licker,et al.  Absence of Beneficial Effect of Acute Normovolemic Hemodilution Combined with Aprotinin on Allogeneic Blood Transfusion Requirements in Cardiac Surgery , 2002, Anesthesiology.

[236]  R. Hall,et al.  Does Hemoglobin Concentration Affect Perioperative Myocardial Lactate Flux in Patients Undergoing Coronary Artery Bypass Surgery? , 1995, Anesthesia and Analgesia.

[237]  B. Walpoth,et al.  [Quantitative and qualitative analysis of various blood-preserving measures in heart surgery]. , 1990, Swiss medical weekly.

[238]  P. Davis,et al.  The cardiac factor in stroke. , 1992, Current Opinion in Neurology and Neurosurgery.

[239]  V. Gott,et al.  Autotransfusion of shed mediastinal blood after cardiac surgery: a prospective study. , 1978, The Journal of thoracic and cardiovascular surgery.

[240]  Y. Okita,et al.  Coagulation and fibrinolysis system in aortic surgery under deep hypothermic circulatory arrest with aprotinin: the importance of adequate heparinization. , 1997, Circulation.

[241]  A. Keats,et al.  Low activated coagulation time during cardiopulmonary bypass does not increase postoperative bleeding. , 1990, The Annals of thoracic surgery.

[242]  R. Feins,et al.  Reinfusion of shed blood after coronary operation causes elevation of cardiac enzyme levels. , 1992, The Annals of thoracic surgery.

[243]  D. Koppel,et al.  The platelet thrombin receptor and postoperative bleeding. , 1998, The Annals of thoracic surgery.

[244]  P. Feindt,et al.  Predictors of Homologous Blood Transfusion for Patients Undergoing Open Heart Surgery , 2003, The Thoracic and cardiovascular surgeon.

[245]  F. Jubran,et al.  Evaluation of a new blood‐conserving arterial line system for patients in intensive care units , 1993, Critical care medicine.

[246]  O. Ponzio,et al.  Reduction of the inflammatory response following coronary bypass grafting with total minimal extracorporeal circulation. , 2002, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[247]  D. Fullerton,et al.  Use of human rocombinant erythropoietin to correct severe preoperative anemia. , 1991, The Annals of thoracic surgery.

[248]  L. Gray,et al.  Intraoperative Autotransfusion: Experience in 725 Consecutive Cases , 1983, Annals of surgery.

[249]  S. Hill,et al.  Safety and preliminary efficacy of hemoglobin raffimer for patients undergoing coronary artery bypass surgery. , 2002, Journal of cardiothoracic and vascular anesthesia.

[250]  A. Stammers,et al.  Quantitative evaluation of heparin-coated versus non-heparin-coated bypass circuits during cardiopulmonary bypass. , 1999, The journal of extra-corporeal technology.

[251]  A. Laupacis,et al.  Drugs to Minimize Perioperative Blood Loss in Cardiac Surgery: Meta-Analyses Using Perioperative Blood Transfusion As the Outcome , 1997, Anesthesia and analgesia.

[252]  M. Popovsky,et al.  Intraoperative autologous transfusion. , 1985, Mayo Clinic proceedings.

[253]  Terry N. Crane,et al.  MEMBRANE VERSUS BUBBLE OXYGENATORS: A CLINICAL COMPARISON OF POSTOPERATIVE BLOOD LOSS. , 1979, Cardiovascular diseases.

[254]  J. Hammon,et al.  Does the combination of aprotinin and angiotensin-converting enzyme inhibitor cause renal failure after cardiac surgery? , 2005, The Annals of thoracic surgery.

[255]  H. Yip,et al.  A safe and effective regimen without heparin therapy after successful primary coronary stenting in patients with acute myocardial infarction. , 2000, Japanese heart journal.

[256]  Deepak L. Bhatt,et al.  Enhanced Efficacy of Eptifibatide Administration in Patients With Acute Coronary Syndrome Requiring In-Hospital Coronary Artery Bypass Grafting , 2000, Circulation.

[257]  O. Alfieri,et al.  Tranexamic acid compared with high-dose aprotinin in primary elective heart operations: effects on perioperative bleeding and allogeneic transfusions. , 2000, The Journal of thoracic and cardiovascular surgery.

[258]  D. Lane,et al.  Neutralization of heparin-related saccharides by histidine-rich glycoprotein and platelet factor 4. , 1986, The Journal of biological chemistry.

[259]  A. Hartz,et al.  A comparison of observational studies and randomized, controlled trials. , 2000, The New England journal of medicine.

[260]  G. Beller,et al.  Short-term infarct vessel patency with aspirin and dipyridamole started 24 to 36 hours after intravenous streptokinase. , 1988, American Heart Journal.

[261]  B. Boneu,et al.  The role of the hematocrit in bleeding. , 1987, Transfusion medicine reviews.

[262]  Bryan C Collier,et al.  Prophylactic positive end-expiratory pressure and reduction of postoperative blood loss in open-heart surgery. , 2002, The Annals of thoracic surgery.

[263]  G. Gravlee,et al.  Heparin management protocol for cardiopulmonary bypass influences postoperative heparin rebound but not bleeding. , 1992, Anesthesiology.

[264]  M L Lesser,et al.  Impact of minimum hematocrit during cardiopulmonary bypass on mortality in patients undergoing coronary artery surgery. , 1997, Circulation.

[265]  N. Altorki,et al.  The effects of platelet inhibitors on blood use in cardiac surgery , 2002, Perfusion.

[266]  J. Marshall,et al.  Is a low transfusion threshold safe in critically ill patients with cardiovascular diseases? , 2001, Critical care medicine.

[267]  M. Hadamitzky,et al.  A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. , 1996, The New England journal of medicine.

[268]  L. Cohn,et al.  Aprotinin in primary valve replacement and reconstruction: a multicenter, double-blind, placebo-controlled trial. , 1996, The Journal of thoracic and cardiovascular surgery.

[269]  R. Mammana,et al.  Determinants of homologous blood usage utilizing autologous platelet-rich plasma in cardiac operations. , 1989, The Annals of thoracic surgery.

[270]  H. Bentall,et al.  BLOOD-LOSS AFTER CARDIOPULMONARY BYPASS. , 1964, The Lancet.

[271]  M. Yoshikai,et al.  Clinical evaluation of the centrifugal pump in open heart surgery: a comparative study of different pumps. , 1997, Artificial organs.

[272]  J. Hirsh.  Drug therapy : heparin , 1991 .

[273]  S. Siitonen,et al.  Activation of neutrophils and monocytes by a leukocyte-depleting filter used throughout cardiopulmonary bypass. , 2005, The Journal of thoracic and cardiovascular surgery.

[274]  M. Laato,et al.  Use of activated clotting time to monitor anticoagulation during cardiac surgery. , 1984, Scandinavian journal of thoracic and cardiovascular surgery.

[275]  S. Cain,et al.  The physiologic reserve in oxygen carrying capacity: studies in experimental hemodilution. , 1986, Canadian journal of physiology and pharmacology.

[276]  J. Sixma,et al.  Correction of the Bleeding Time in Patients with Storage Pool Deficiency by Infusion of Cryoprecipitate , 1978, British Journal of Haematology.

[277]  J. Bachet,et al.  The use of biological glue in aortic surgery. , 1999, Cardiology clinics.

[278]  T. Yamada,et al.  [Autologous blood donation with recombinant human erythropoietin prior to elective cardiac surgery in anemic patients]. , 1998, Kyobu geka. The Japanese journal of thoracic surgery.

[279]  S. Bélisle,et al.  Hemorrhage and the use of blood products after adult cardiac operations: myths and realities. , 1996, The Annals of thoracic surgery.

[280]  M. Valbonesi,et al.  A new technique for hemodilution, preparation of autologous platelet-rich plasma and intraoperative blood salvage in cardiac surgery , 1987, The International journal of artificial organs.

[281]  K. Preissner,et al.  Physicochemical characterization of human S-protein and its function in the blood coagulation system. , 1985, The Biochemical journal.

[282]  S. Jubelirer.  Coronary artery bypass in two patients with immune thrombocytopenic purpura without preoperative splenectomy. , 1992, West Virginia Medical Journal.

[283]  T. Fischlein.  Gerinnungsstörungen in der Herzchirurgie , 2000, Hämostaseologie.

[284]  B. Medalion,et al.  Tranexamic acid reduces bleeding and the need for blood transfusion in primary myocardial revascularization. , 2002, Annals of Thoracic Surgery.

[285]  A. Grindon,et al.  Platelet support for cardiopulmonary bypass surgery. , 1975, The Journal of thoracic and cardiovascular surgery.

[286]  P. Nataf,et al.  [Systematic peroperative use of an autotransfusion system in heart surgery. A prospective and comparative study in 283 patients]. , 1989, Archives des maladies du coeur et des vaisseaux.

[287]  C. Franklin,et al.  Results of surgical treatment for infective endocarditis in intravenous drug users. , 1995, Chest.

[288]  P. Morateck,et al.  The critical interaction of glycoprotein (GP) IBbeta with GPIX-a genetic cause of Bernard-Soulier syndrome. , 1999, Blood.

[289]  A. Berman,et al.  Effect of continuous quality improvement analysis on the delivery of primary percutaneous transluminal coronary angioplasty for acute myocardial infarction. , 1997, American Journal of Cardiology.

[290]  D. Tempe,et al.  Comparison of the effects of a cell saver and low-dose aprotinin on blood loss and homologous blood usage in patients undergoing valve surgery. , 2001, Journal of cardiothoracic and vascular anesthesia.

[291]  T. Speroff,et al.  The economic benefit of organizational restructuring of the cardiothoracic intensive care unit. , 2003, Journal of Cardiothoracic and Vascular Anesthesia.

[292]  O. Alfieri,et al.  Postinfarction Left Ventricular Free Wall Rupture: Original Management and Surgical Technique , 1991, Journal of cardiac surgery.

[293]  H. Corwin,et al.  RBC transfusion in the ICU. Is there a reason? , 1995, Chest.

[294]  L. McGrath,et al.  Effectiveness of fibrin glue in the reduction of postoperative intrapericardial adhesions. , 1996, Journal of investigative surgery : the official journal of the Academy of Surgical Research.

[295]  F. Turani,et al.  Haemodynamic and volumetric response to tidal volume and positive end expiratory pressure variation in acute lung injury/acute respiratory distress syndrome patients , 2004, Critical Care.

[296]  C. Dyke,et al.  Inhibitors of the platelet receptor glycoprotein IIb-IIIa and complications during percutaneous coronary revascularization. Management strategies for the cardiac surgeon. , 1999, The Journal of cardiovascular surgery.

[297]  J. Chamberlin,et al.  Use of vascular sealing devices (VasoSeal and Perclose) versus assisted manual compression (Femostop) in transcatheter coronary interventions requiring Abciximab (ReoPro) , 1999, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[298]  T. Treasure,et al.  Effect of aprotinin on clinical outcomes in coronary artery bypass graft surgery: a systematic review and meta-analysis of randomized clinical trials. , 2004, The Journal of thoracic and cardiovascular surgery.

[299]  J. Zimmerman,et al.  Initial evaluation of a new intra‐arterial blood gas system in humans , 1993, Critical Care Medicine.

[300]  J. Concato,et al.  Randomized, controlled trials, observational studies, and the hierarchy of research designs. , 2000, The New England journal of medicine.

[301]  T. Åberg,et al.  Use of Heparin-bonded Circuits in Cardiopulmonary Bypass Improves Clinical Outcome , 2002, Scandinavian Cardiovascular Journal.

[302]  S. Khuri,et al.  The effects of aspirin and hypothermia on platelet function in vivo , 1999, British journal of haematology.

[303]  M. Brophy,et al.  The bleeding time response to aspirin. Identifying the hyperresponder. , 1990, American Journal of Clinical Pathology.

[304]  M. Davies,et al.  Blood-conservation techniques for coronary-artery bypass surgery at a private hospital. , 1989, The Medical journal of Australia.

[305]  P. Biglioli,et al.  The effect of "high dose" aprotinin and other factors on bleeding and revisions for bleeding in adult coronary and valve operations: an analysis of 2190 patients during a five-year period (1987-1991). , 1995, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[306]  Edward L Snyder,et al.  Reduction of febrile but not allergic reactions to RBCs and platelets after conversion to universal prestorage leukoreduction , 2004, Transfusion.

[307]  Nugent Wc.  Benchmarking cardiac surgery: a regional initiative to improve outcomes. Interview by Reggi Veatch. , 1994 .

[308]  K. Skarvan,et al.  Reduction of Blood Loss and Transfusion Requirements After Coronary Artery Bypass Grafting: , 1999 .

[309]  T. Investigators.  Effects of platelet glycoprotein IIb/IIIa blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty. The RESTORE Investigators. Randomized Efficacy Study of Tirofiban for Outcomes and REstenosis. , 1997, Circulation.

[310]  R. Lundblad,et al.  Neutralization of heparin activity by neutrophil lactoferrin , 1995 .

[311]  R. Habib,et al.  Effects of body size on operative, intermediate, and long-term outcomes after coronary artery bypass operation. , 2001, Annals of Thoracic Surgery.

[312]  A. Cribier,et al.  Intracoronary stent implantation without ultrasound guidance and with replacement of conventional anticoagulation by antiplatelet therapy. 30-day clinical outcome of the French Multicenter Registry. , 1996, Circulation.

[313]  W. Vanoeveren,et al.  CONTACT, COAGULATION AND PLATELET INTERACTION WITH HEPARIN TREATED EQUIPMENT DURING HEART-SURGERY , 1993 .

[314]  M. Rossi,et al.  A pump-prime aprotinin dose in cardiac surgery: appraisal of its effects on the hemostatic system. , 1997, Journal of Cardiothoracic and Vascular Anesthesia.

[315]  P. Stein,et al.  Antithrombotic therapy in patients with saphenous vein and internal mammary artery bypass grafts. , 1995, Chest.

[316]  S. Pugh,et al.  A comparison of the effects of tranexamic acid and low-dose aprotinin on blood loss and homologous blood usage in patients undergoing cardiac surgery. , 1995, Journal of cardiothoracic and vascular anesthesia.

[317]  C. Sintek,et al.  Intraoperative autotransfusion reduces blood loss after cardiopulmonary bypass. , 1996, The Annals of thoracic surgery.

[318]  D. Spahn,et al.  Acute normovolemic hemodilution: physiology, limitations, and clinical use. , 2003, Journal of cardiothoracic and vascular anesthesia.

[319]  J. Brinker,et al.  A multicenter randomized trial comparing a percutaneous collagen hemostasis device with conventional manual compression after diagnostic angiography and angioplasty. , 1993, Journal of the American College of Cardiology.

[320]  T. Reffelmann,et al.  [Reduction of in-hospital complications after elective percutaneous transluminal coronary angioplasty using a combined pretreatment with ticlopidine and aspirin]. , 1998, Zeitschrift für Kardiologie.

[321]  T. Simon,et al.  Controlled trial of routine administration of platelet concentrates in cardiopulmonary bypass surgery. , 1984, The Annals of thoracic surgery.

[322]  I. Matot,et al.  Effectiveness of Acute Normovolemic Hemodilution to Minimize Allogeneic Blood Transfusion in Major Liver Resections , 2002, Anesthesiology.

[323]  J. Birkmeyer,et al.  Trends in rates of reexploration for hemorrhage after coronary artery bypass surgery. Northern New England Cardiovascular Disease Study Group. , 1999, The Annals of thoracic surgery.

[324]  R. Marquet,et al.  Efficacy of recombinant erythropoietin for stimulating erythropoiesis after blood loss and surgery. An experimental study in rats. , 1992, The European journal of surgery = Acta chirurgica.

[325]  R. Hall,et al.  The benefit of the Hemonetics® cell saver apparatus during cardiac surgery , 1990, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[326]  V. Fuster,et al.  The Relationships Among Dose, Effectiveness, and Side Effects , 1998 .

[327]  B. Silbert,et al.  Blood loss in elective coronary artery surgery: a comparison of centrifugal versus roller pump heads during cardiopulmonary bypass. , 2001, Journal of cardiothoracic and vascular anesthesia.

[328]  J. E. Doran,et al.  Comparison of the effects of aprotinin and tranexamic acid on blood loss and related variables after cardiopulmonary bypass. , 1994, The Journal of thoracic and cardiovascular surgery.

[329]  L. Goodnough,et al.  Blood lost and blood transfused in coronary artery bypass graft operation as implications for blood transfusion and blood conservation strategies. , 1993, Surgery, gynecology & obstetrics.

[330]  K. Wernecke,et al.  Recombinant activated factor VII for refractory bleeding after cardiac surgery—A retrospective analysis of safety and efficacy , 2005, Critical Care Medicine.

[331]  J. Birkmeyer,et al.  Economic impact of inappropriate blood transfusions in coronary artery bypass graft surgery. , 1993, The American journal of medicine.

[332]  D. Bainbridge,et al.  Does Off-pump Coronary Artery Bypass Reduce Mortality, Morbidity, and Resource Utilization When Compared with Conventional Coronary Artery Bypass? A Meta-analysis of Randomized Trials , 2005, Anesthesiology.

[333]  J. Gibson,et al.  Intraoperative Plateletpheresis and Autologous Platelet Gel Do Not Reduce Chest Tube Drainage or Allogeneic Blood Transfusion After Reoperative Coronary Artery Bypass Graft , 2001, Anesthesia and analgesia.

[334]  R. Shemin,et al.  Heparin-bonded circuits with a reduced anticoagulation protocol in primary CABG: a prospective, randomized study. , 1996, The Annals of thoracic surgery.

[335]  G. Keating,et al.  Eptifibatide , 2012, Drugs.

[336]  M. Newman,et al.  epsilon-Aminocaproic Acid Plasma Levels During Cardiopulmonary Bypass , 1997, Anesthesia and analgesia.

[337]  V. Gaudiani,et al.  Preoperative erythropoietin in Jehovah's Witnesses who require cardiac procedures. , 1991, The Annals of thoracic surgery.

[338]  H. Taswell,et al.  Transfusion Reactions Associated with Anti‐IgA Antibodies: Report of Four Cases and Review of the Literature , 2003, Transfusion.

[339]  T. Barrowcliffe,et al.  The influence of tissue source, salt and molecular weight and heparin activity. , 2009, Scandinavian journal of haematology. Supplementum.

[340]  L. Goodnough,et al.  Transfusion medicine: looking to the future , 2003, The Lancet.

[341]  A. Cribier,et al.  A randomized comparison of a percutaneous suture device versus manual compression for femoral artery hemostasis after PTCA. , 2003, Journal of interventional cardiology.

[342]  D. Menzies,et al.  Autotransfusion of shed mediastinal blood: a risk factor for mediastinitis after cardiac surgery? Results of a cluster investigation. , 2003, Chest.

[343]  K. Goa,et al.  Eptifibatide , 1999, Drugs.

[344]  S. Ishiguro,et al.  Mitral valve repair for mitral insufficiency due to infective endocarditis in a patient with idiopathic thrombocytopenic purpura. , 2005, Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia.

[345]  J. Brinker,et al.  A multicenter randomized trial comparing a percutaneous collagen hemostasis device with conventional manual compression after diagnostic angiography and angioplasty. , 1999, The Journal of invasive cardiology.

[346]  T. Rosengart,et al.  Open heart operations without transfusion using a multimodality blood conservation strategy in 50 Jehovah's Witness patients: implications for a "bloodless" surgical technique. , 1997, Journal of the American College of Surgeons.

[347]  Linda J Stang,et al.  Coronary artery bypass surgery with heparin-coated perfusion circuits and low-dose heparinization. , 2002, Canadian journal of surgery. Journal canadien de chirurgie.

[348]  R. Pifarré,et al.  Monitoring of intraoperative heparinization and blood loss following cardiopulmonary bypass surgery. , 1977, The Journal of thoracic and cardiovascular surgery.

[349]  J. van der Linden,et al.  Heparin coating reduces blood cell adhesion to arterial filters during coronary bypass: a clinical study. , 1993, The Annals of thoracic surgery.

[350]  Takesada Mori,et al.  Clinical application of a newin vitro bleeding time device on surgical patients , 1988, The Japanese journal of surgery.

[351]  G. Lemole,et al.  Transfusion after coronary artery bypass surgery: the impact of heparin-bonded circuits. , 1999, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[352]  J. Civetta,et al.  Maintaining Quality of Care While Reducing Charges in the ICU , 1985, Annals of surgery.

[353]  R. Mohr,et al.  Effect of cardiac operation on platelets. , 1986, The Journal of thoracic and cardiovascular surgery.

[354]  R. Groom.  High or low hematocrits during cardiopulmonary bypass for patients undergoing coronary artery bypass graft surgery? An evidence-based approach to the question , 2001, Perfusion.

[355]  N. Mills,et al.  Positive end-expiratory pressure in the management of the patient with a postoperative bleeding heart. , 1980, The Annals of thoracic surgery.

[356]  Diana B. Petitti,et al.  Meta-Analysis, Decision Analysis, and Cost-Effectiveness Analysis: Methods for Quantitative Synthesis in Medicine , 1994 .

[357]  D. Wheeldon,et al.  Vortex pumping for routine cardiac surgery: a comparative study , 1990, Perfusion.

[358]  C. Tribouilloy,et al.  Aortic valve replacement with the minimal extracorporeal circulation (Jostra MECC System) versus standard cardiopulmonary bypass: a randomized prospective trial. , 2004, The Journal of thoracic and cardiovascular surgery.

[359]  B. Akl,et al.  Clinical experience with the activated clotting time for the control of heparin and protamine therapy during cardiopulmonary bypass. , 1980, The Journal of thoracic and cardiovascular surgery.

[360]  J. Fontcuberta,et al.  The effect of two different doses of aprotinin on hemostasis in cardiopulmonary bypass surgery: similar transfusion requirements and blood loss. , 2000, Haematologica.

[361]  J. Zwischenberger,et al.  Adverse effects of postoperative infusion of shed mediastinal blood. , 1996, The Annals of thoracic surgery.

[362]  G. Chiaudani,et al.  [Aprotinin in cardiosurgery: a randomized prospective study with different protocols for use]. , 1990, Minerva anestesiologica.

[363]  W. Baumgartner,et al.  Heparin-coated bypass circuits reduce pulmonary injury. , 1993, The Annals of thoracic surgery.

[364]  S. Fremes,et al.  Aprotinin and tranexamic acid for high transfusion risk cardiac surgery. , 2000, The Annals of thoracic surgery.

[365]  H. Schaff,et al.  Effect of blood conservation efforts in cardiac operations at the Mayo Clinic. , 1988, Mayo Clinic proceedings.

[366]  Benveniste,et al.  The MUST Trial: Acute Results and Six-Month Clinical Follow-up. , 1998, The Journal of invasive cardiology.

[367]  L. Shore-lesserson.  Monitoring anticoagulation and hemostasis in cardiac surgery. , 2003, Anesthesiology clinics of North America.

[368]  David J Cohen,et al.  Stent Thrombosis After Successful Sirolimus-Eluting Stent Implantation , 2004, Circulation.

[369]  G. Remuzzi,et al.  URAEMIC BLEEDING: ROLE OF ANAEMIA AND BENEFICIAL EFFECT OF RED CELL TRANSFUSIONS , 1982, The Lancet.

[370]  Taper,et al.  Cardiac surgery and catheterization in patients with Haemophilia , 2000, Haemophilia : the official journal of the World Federation of Hemophilia.

[371]  P. Hanrath,et al.  Reduktion von Krankenhauskomplikationen nach elektiver perkutaner transluminaler Koronarangioplastie bei kombinierter Vorbehandlung mit Ticlopidin und Acetylsalicylsäure , 1998, Zeitschrift für Kardiologie.

[372]  R. Helm,et al.  Development and Application of a Multimodality Blood Conservation Program , 1998 .

[373]  G. Speziali,et al.  Intraoperative Low-volume Acute Normovolemic Hemodilution in Adult Open-heart Surgery , 2002, Anesthesiology.

[374]  G. Nuttall,et al.  Efficacy of a Simple Intraoperative Transfusion Algorithm for Nonerythrocyte Component Utilization after Cardiopulmonary Bypass , 2001, Anesthesiology.

[375]  W. van Oeveren,et al.  Aprotinin effect on platelet function and clotting during cardiopulmonary bypass. , 1994, European Journal of Cardio-Thoracic Surgery.

[376]  E. Topol,et al.  Bivalirudin versus heparin during coronary angioplasty for unstable or postinfarction angina: Final report reanalysis of the Bivalirudin Angioplasty Study. , 2001, American heart journal.

[377]  A. Starr,et al.  Effects of infusion of cardiotomy suction blood during extracorporeal circulation for coronary artery bypass surgery. , 1977, The Journal of thoracic and cardiovascular surgery.

[378]  M. Bell,et al.  Immediate ambulation following diagnostic coronary angiography procedures utilizing a vascular closure device (The Closer). , 2002, The Journal of invasive cardiology.

[379]  A. Scheule,et al.  Forty years of clinical aprotinin use: a review of 124 hypersensitivity reactions. , 2005, The Annals of thoracic surgery.

[380]  G. Patterson,et al.  A reevaluation of heparin requirements for cardiopulmonary bypass. , 1991, The Journal of thoracic and cardiovascular surgery.

[381]  N. Kabakuş,et al.  Investigation of platelet aggregation by impedance and optic methods in children with iron deficiency anaemia. , 2000, Haematologia.

[382]  P. Mongan,et al.  Tranexamic Acid and Aprotinin Reduce Postoperative Bleeding and Transfusions During Primary Coronary Revascularization , 1998, Anesthesia and analgesia.

[383]  J. Utley.  Historical perspectives and basic pathophysiology. , 1990, Seminars in thoracic and cardiovascular surgery.

[384]  G. Hafner,et al.  Reoperation and the centrifugal pump? , 1992, European Journal of Cardio-Thoracic Surgery.

[385]  J. Schved.  Preoperative autologous blood donation: a therapy that needs to be scientifically evaluated. , 2005, Transfusion Clinique et Biologique.

[386]  M. Borger,et al.  Low hematocrit during cardiopulmonary bypass is associated with increased risk of perioperative stroke in cardiac surgery. , 2005, The Annals of thoracic surgery.

[387]  D. Royston,et al.  Safety aspects of aprotinin therapy in cardiac surgery patients , 2006, Expert opinion on drug safety.

[388]  J. Babin-Ebell,et al.  A Comparative Evaluation of the Effect of Pump Type and Heparin-Coated Surfaces on Platelets during Cardiopulmonary Bypass , 1997, The Thoracic and cardiovascular surgeon.

[389]  C. Naylor,et al.  Metaanalysis of prophylactic drug treatment in the prevention of postoperative bleeding. , 1994, The Annals of thoracic surgery.

[390]  L. Mickleborough,et al.  Limitations of blood conservation. , 1984, The Journal of thoracic and cardiovascular surgery.

[391]  L. Cohn,et al.  Reducing costs and length of stay and improving efficiency and quality of care in cardiac surgery. , 1997, The Annals of thoracic surgery.

[392]  E. Michelson,et al.  Early recognition of surgically correctable causes of excessive mediastinal bleeding after coronary artery bypass graft surgery. , 1980, American journal of surgery.

[393]  S. Bhakdi,et al.  Deposition of terminal C5b-9 complement complexes on erythrocytes and leukocytes during cardiopulmonary bypass. , 1988, The New England journal of medicine.

[394]  E. Ovrum,et al.  Elective coronary artery bypass surgery without homologous blood transfusion. Early results with an inexpensive blood conservation program. , 1991, Scandinavian Journal of Thoracic and Cardiovascular Surgery.

[395]  H. Harke,et al.  [Effect of a preoperative separation of platelets on the postoperative blood loss subsequent to extracorporeal circulation in open heart surgery (author's transl)]. , 1977, Der Anaesthesist.

[396]  F. Tomai,et al.  Intraoperative antifibrinolysis and blood-saving techniques in cardiac surgery. Prospective trial of 3 antifibrinolytic drugs. , 1995, Texas Heart Institute journal.

[397]  H. Macvaugh,et al.  Control of postcardiotomy bleeding with PEEP. , 1982, Annals of Thoracic Surgery.

[398]  H. Hannah,et al.  Autotransfusion of unwashed mediastinal shed blood fails to decrease banked blood requirements in patients undergoing aortocoronary bypass surgery. , 1991, American journal of surgery.

[399]  C. Arkin,et al.  The preoperative bleeding time test lacks clinical benefit: College of American Pathologists' and American Society of Clinical Pathologists' position article. , 1998, Archives of surgery.

[400]  S. Lemeshow,et al.  Late postoperative tamponade following coronary artery bypass grafting in patients on antiplatelet therapy. , 1985, Annals of Thoracic Surgery.

[401]  W. Scott,et al.  Efficacy, complications, and cost of a comprehensive blood conservation program for cardiac operations. , 1992, Journal of Thoracic and Cardiovascular Surgery.

[402]  J. Copeland,et al.  Starting Aspirin Therapy After Operation: Effects on Early Graft Patency , 1991, Circulation.

[403]  B. Ong,et al.  Preoperative plateletpheresis does not reduce blood loss during cardiac surgery , 1993, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[404]  Keyvan Karkouti,et al.  A propensity score case‐control comparison of aprotinin and tranexamic acid in high‐transfusion‐risk cardiac surgery , 2006, Transfusion.

[405]  R. Colman,et al.  Plasma tissue factor plus activated peripheral mononuclear cells activate factors VII and X in cardiac surgical wounds. , 2005, Journal of the American College of Cardiology.

[406]  G. Tangen,et al.  Effects of two differently heparin-coated extracorporeal circuits on markers for brain and myocardial dysfunction , 2002, Perfusion.

[407]  E. Spitznagel,et al.  Preoperative use of enoxaparin increases the risk of postoperative bleeding and re-exploration in cardiac surgery patients. , 2005, Journal of cardiothoracic and vascular anesthesia.

[408]  I. C. Tudor,et al.  The risk associated with aprotinin in cardiac surgery. , 2006, The New England journal of medicine.

[409]  J. Hirsh,et al.  Heparin Binding Proteins Contribution to Heparin Rebound After Cardiopulmonary Bypass , 1993, Circulation.

[410]  G. O'connor,et al.  A methodology for QI in the coronary artery bypass grafting procedure involving comparative process analysis. , 1992, QRB. Quality review bulletin.

[411]  G. Faggian,et al.  [Replacement of the aortic valve with a pulmonary autograft: experience at the University of Verona]. , 1997, Giornale italiano di cardiologia.

[412]  N. Hayashida,et al.  Effects of minimal-dose aprotinin on coronary artery bypass grafting. , 1997, Journal of Thoracic and Cardiovascular Surgery.

[413]  J. Vender,et al.  The Failure of Retrograde Autologous Priming of the Cardiopulmonary Bypass Circuit to Reduce Blood Use After Cardiac Surgical Procedures , 2004, Anesthesia and Analgesia.

[414]  D. Schroeder,et al.  Desmopressin does not reduce bleeding and transfusion requirements in congenital heart operations. , 2000, Annals of Thoracic Surgery.

[415]  G. Raskob,et al.  Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis. , 1986, The New England journal of medicine.

[416]  D. Royston,et al.  Reduced haemostatic factor transfusion using heparinase-modified thrombelastography during cardiopulmonary bypass. , 2001, British journal of anaesthesia.

[417]  J. W. Schaeffer,et al.  ACC/AHA 2002 guideline update for the management of patients with unstable angina and non–ST-segment elevation myocardial infarction—summary article , 2002 .

[418]  R. Habib,et al.  Effect of blood transfusion on long-term survival after cardiac operation. , 2002, The Annals of thoracic surgery.

[419]  M. Oz,et al.  Endotoxin in pooled pericardial blood contributes to the systemic inflammatory response during cardiac surgery , 2000, Perfusion.

[420]  L. Goodnough,et al.  Transfusion Medicine , 2001, American journal of cardiovascular drugs : drugs, devices, and other interventions.

[421]  J. Gold,et al.  Erythropoietin in Cardiac Surgery , 1993, Journal of cardiac surgery.

[422]  J. Vacek,et al.  Differential Benefits and Outcomes of Tirofiban vs Abciximab for Acute Coronary Syndromes in Current Clinical Practice , 2003, Angiology.

[423]  D. Palanzo,et al.  Coronary artery bypass grafting in a patient with haemophilia B , 1995, Perfusion.

[424]  K. Rådegran,et al.  Use of the activated coagulation time in cardiac surgery. Effects on heparin-protamine dosages and bleeding. , 1981, Scandinavian Journal of Thoracic and Cardiovascular Surgery.

[425]  H. Helling,et al.  Membrane versus bubble oxygenator in hyperthermic regional perfusion: a prospective randomized clinical study. , 1994, European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes.

[426]  J. Bennett,et al.  Disorders of platelet function. , 1992, Disease-a-month : DM.

[427]  J. Moake,et al.  In Vitro Comparison of Blood Pump Induced Platelet Microaggregates between a Centrifugal and Roller Pump During Cardiopulmonary Bypass , 2002, The International journal of artificial organs.

[428]  M. Czerny,et al.  Complete revascularization in coronary artery bypass grafting with and without cardiopulmonary bypass. , 2001, The Annals of thoracic surgery.

[429]  O. Taşdemír,et al.  Low-dose oral anticoagulation and antiplatelet therapy with St. Jude Medical heart valve prosthesis. , 1999, Journal of Heart Valve Disease.

[430]  V. Boddi,et al.  High-dose aprotinin: hemostatic effects in open heart operations. , 1989, The Annals of thoracic surgery.

[431]  U. Hvass,et al.  Left ventricular free wall rupture. Long-term results with a pericardial patch and fibrin glue repair. , 1995, European Journal of Cardio-Thoracic Surgery.

[432]  S. Body,et al.  Safety and efficacy of shed mediastinal blood transfusion after cardiac surgery: a multicenter observational study. Multicenter Study of Perioperative Ischemia Research Group. , 1999, Journal of Cardiothoracic and Vascular Anesthesia.

[433]  V. Hasselblad,et al.  Clinical outcomes of bivalirudin for ischemic heart disease. , 1999, Circulation.

[434]  D. Cosgrove,et al.  Randomized clinical trial of fibrin sealant in patients undergoing resternotomy or reoperation after cardiac operations. A multicenter study. , 1989, The Journal of thoracic and cardiovascular surgery.

[435]  Michael Joner,et al.  Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. , 2006, Journal of the American College of Cardiology.

[436]  J. D. Brooks,et al.  Comparison of bubble and membrane oxygenators in short and long perfusions. , 1979, The Journal of thoracic and cardiovascular surgery.

[437]  O. V. Hein,et al.  Protracted bleeding after hirudin anticoagulation for cardiac surgery in a patient with HIT II and chronic renal failure. , 2005, Artificial Organs.

[438]  M. Davies,et al.  Blood‐conservation techniques for coronary‐artery bypass surgery at a private hospital , 1988 .

[439]  R. Michler,et al.  Recombinant Factor VIIa to Control Excessive Bleeding Following Surgery for Congenital Heart Disease in Pediatric Patients , 2004, Journal of intensive care medicine.

[440]  K. C. Anderson,et al.  Guidelines for blood utilization review , 1994, Transfusion.

[441]  S. J. Ley.  Quality care outcomes in cardiac surgery: the role of evidence-based practice. , 2001, AACN clinical issues.

[442]  M. Pfisterer,et al.  TRIAL OF LOW-DOSE ASPIRIN PLUS DIPYRIDAMOLE VERSUS ANTICOAGULANTS FOR PREVENTION OF AORTOCORONARY VEIN GRAFT OCCLUSION , 1989, The Lancet.

[443]  W. White,et al.  Cost‐Benefit and Efficacy of Aprotinin Compared with ε‐Aminocaproic Acid in Patients Having Repeated Cardiac Operations: A Randomized, Blinded Clinical Trial , 1997 .

[444]  J. Birkmeyer,et al.  Safety of the Blood Supply in the United States: Opportunities and Controversies , 1997, Annals of Internal Medicine.

[445]  E. Fosse,et al.  Duraflo II coating of cardiopulmonary bypass circuits reduces complement activation, but does not affect the release of granulocyte enzymes : a European multicentre study. , 1997, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[446]  W. Beattie,et al.  Platelet transfusions are not associated with increased morbidity or mortality in cardiac surgery , 2006, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[447]  D. Reich,et al.  Autologous Platelet-Rich Plasmapheresis: Risk Versus Benefit in Repeat Cardiac Operations , 1995, Anesthesia and Analgesia.

[448]  W. van Oeveren,et al.  Contact, coagulation and platelet interaction with heparin treated equipment during heart surgery. , 1993, The International journal of artificial organs.

[449]  Kuitunen Ah.  Haemostatic responses to desmopressin acetate after primary coronary artery bypass surgery. , 1992 .

[450]  A. Merry,et al.  Bivalirudin versus heparin and protamine in off-pump coronary artery bypass surgery. , 2004, The Annals of thoracic surgery.

[451]  Staffan Bjessmo, Torbjörn Ivert.  Blood Loss After Coronary Artery Bypass Surgery: Relations to Patient Variables and Antithrombotic Treatment , 2000, Scandinavian cardiovascular journal : SCJ.

[452]  D. Reboussin,et al.  Cardiotomy suction: a major source of brain lipid emboli during cardiopulmonary bypass. , 1998, The Annals of thoracic surgery.

[453]  I. Paşaoǧlu,et al.  The effect of acute normovolemic hemodilution on homologous blood requirements and total estimated red blood cell volume lost , 1997, Acta anaesthesiologica Scandinavica.

[454]  F. Maly,et al.  Modified ultrafiltration lowers adhesion molecule and cytokine levels after cardiopulmonary bypass without clinical relevance in adults. , 2000, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[455]  W. Scott,et al.  Blood conservation in cardiac surgery. , 1990, The Annals of thoracic surgery.

[456]  K. Abbott,et al.  The impact of bleeding times on major complication rates after percutaneous real-time ultrasound-guided renal biopsies. , 2001, JN. Journal of Nephrology (Milano. 1992).

[457]  S. Israels,et al.  Development of Antibodies to Bovine and Human Factor V in Two Children After Exposure to Topical Bovine Thrombin , 1994, American Journal Of Pediatric Hematology/Oncology.

[458]  S. Ferraris,et al.  Preoperative aspirin ingestion increases operative blood loss after coronary artery bypass grafting. , 1988, The Annals of thoracic surgery.

[459]  B. Spiess,et al.  Changes in transfusion therapy and reexploration rate after institution of a blood management program in cardiac surgical patients. , 1995, Journal of cardiothoracic and vascular anesthesia.

[460]  O. Dale,et al.  Single-Dose Tranexamic Acid Reduces Postoperative Bleeding After Coronary Surgery in Patients Treated with Aspirin Until Surgery , 2003, Anesthesia and analgesia.

[461]  C. Deakin,et al.  Autotransfusion Decreases Blood Usage following Cardiac Surgery — a Prospective Randomized Trial , 2001, Cardiovascular surgery.

[462]  J. Carson,et al.  Mortality and morbidity in patients with very low postoperative Hb levels who decline blood transfusion , 2002, Transfusion.

[463]  R. Moore,et al.  The impact of intraoperative autotransfusion on cardiac surgery. A prospective randomized double-blind study. , 1993, Chest.

[464]  Ren Li.  Left ventricular rupture following mitral valve replacement , 2000 .

[465]  G. Vlahakes.  The value of phase 4 clinical testing. , 2006, New England Journal of Medicine.

[466]  J. Fortenberry,et al.  Modifying risk for extracorporeal circulation: trial of four antiinflammatory strategies. , 1998, The Annals of thoracic surgery.

[467]  Relman As,et al.  Assessment and accountability: the third revolution in medical care. , 1988 .

[468]  R. Ponlot,et al.  Hæmostasis Disorders in Open Heart Surgery with Extracorporeal Circulation: Importance of the Platelet Function and the Heparin Neutralization , 1977, Vox sanguinis.

[469]  Paweł Szczerkowski.  [The effect of reinfusion of mediastinal blood drained after coronary surgery on coagulation, fibrinolysis and volume of blood products transfused]. , 2003, Annales Academiae Medicae Stetinensis.

[470]  E. Topol,et al.  Peripheral vascular complications after conventional and complex percutaneous coronary interventional procedures. , 1992, The American journal of cardiology.

[471]  T. Yamada,et al.  Autologous blood donation with recombinant human erythropoietin in anemic patients. , 1999, The Annals of thoracic surgery.

[472]  T. Datta,et al.  Clinical spectrum of Glanzmann's thrombasthenia. , 2000, Indian Journal of Pathology and Microbiology.

[473]  F. Loop,et al.  Determinants of blood utilization during myocardial revascularization. , 1985, The Annals of thoracic surgery.

[474]  M. Welte,et al.  Use of Perflubron Emulsion to Decrease Allogeneic Blood Transfusion in High-blood-loss Non-Cardiac Surgery: Results of a European Phase 3 Study , 2002, Anesthesiology.

[475]  A. Weaver,et al.  Autologous Platelet-rich Plasma Does Not Reduce Transfusion of Homologous Blood Products in Patients Undergoing Repeat Valvular Surgery , 1993, Anesthesiology.

[476]  A. Kuitunen.  Haemostatic responses to desmopressin acetate after primary coronary artery bypass surgery. , 1992, Annales chirurgiae et gynaecologiae.

[477]  R. Weintraub,et al.  Comparison of two transfusion strategies after elective operations for myocardial revascularization. , 1992, The Journal of thoracic and cardiovascular surgery.

[478]  C. Lynch,et al.  Treatment with desmopressin acetate in routine coronary artery bypass surgery to improve postoperative hemostasis. , 1990, Circulation.

[479]  P. Risteski,et al.  The use of minimized extracorporeal circulation system has a beneficial effect on hemostasis--a randomized clinical study. , 2006, The heart surgery forum.

[480]  R. Helsel,et al.  Conventional haemofiltration during routine coronary bypass surgery , 1997, Perfusion.

[481]  D. Roberts,et al.  Effect of reduced aprotinin dosage on blood loss and use of blood products in patients undergoing cardiopulmonary bypass. , 1993, Scandinavian journal of thoracic and cardiovascular surgery.

[482]  D. Wheatley,et al.  Low-dose preoperative aspirin therapy, postoperative blood loss, and transfusion requirements. , 1990, The Annals of thoracic surgery.

[483]  Y. Yoon,et al.  Usefulness of cilostazol versus ticlopidine in coronary artery stenting. , 1999, The American journal of cardiology.

[484]  R. Weiskopf,et al.  What can we learn about the need for transfusion from patients who refuse blood? The experience with Jehovah's Witnesses , 1994, Transfusion.

[485]  R. Lust,et al.  In-line leukocyte filtration during bypass. Clinical results from a randomized prospective trial. , 1996, ASAIO journal (1992).

[486]  J. Roth,et al.  Use of activated coagulation time to monitor heparin during cardiac surgery. , 1979, The Annals of thoracic surgery.

[487]  J. Svennevig,et al.  Complement activation during extracorporeal circulation. In vitro comparison of Duraflo II heparin-coated and uncoated oxygenator circuits. , 1993, The Journal of thoracic and cardiovascular surgery.

[488]  R. Camishion,et al.  Transfusion guidelines for cardiovascular surgery: lessons learned from operations in Jehovah's Witnesses. , 1992, Journal of vascular surgery.

[489]  R. Harrington,et al.  Immediate coronary artery bypass surgery after platelet inhibition with eptifibatide: results from PURSUIT. Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrelin Therapy. , 2000, The Annals of thoracic surgery.

[490]  W. van Oeveren,et al.  Retransfusion of suctioned blood during cardiopulmonary bypass impairs hemostasis. , 1995, The Annals of thoracic surgery.

[491]  B. Spiess.  Choose one: damned if you do/damned if you don't! , 2005, Critical Care Medicine.

[492]  J. Freedman,et al.  Platelet cold agglutinins: a flow cytometric analysis. , 1998, Transfusion science.

[493]  P. Sloane,et al.  Effects of Off-Pump Coronary Artery Bypass Grafting on Patient Outcome , 2003, Journal of Investigative Medicine.

[494]  J. Gaynor.  The effect of modified ultrafiltration on the postoperative course in patients with congenital heart disease. , 2003, Seminars in Thoracic and Cardiovascular Surgery Pediatric Cardiac Surgery Annual.

[495]  N. Kitamura,et al.  Left ventricular rupture following mitral valve replacement. , 1993, Chest.

[496]  P. Montravers,et al.  Hemodynamic and echocardiographic effects of hemofiltration performed during cardiopulmonary bypass. , 2000, Journal of Cardiothoracic and Vascular Anesthesia.

[497]  A. Peral,et al.  [Use of high doses of aprotinin in cardiac surgery]. , 1994, Revista espanola de anestesiologia y reanimacion.

[498]  L. Smith,et al.  Acute isovolemic hemodilution and blood transfusion. Effects on regional function and metabolism in myocardium with compromised coronary blood flow , 1993 .

[499]  G. Gravlee,et al.  Heparin dosing and monitoring for cardiopulmonary bypass. A comparison of techniques with measurement of subclinical plasma coagulation. , 1990, The Journal of thoracic and cardiovascular surgery.

[500]  G. Tenderich,et al.  Heparin-coated extracorporeal circulation with full and low dose heparinization: comparison of thrombin related coagulatory effects. , 2001, Artificial organs.

[501]  M. Turina,et al.  Low-dose heparin versus full-dose heparin with high-dose aprotinin during cardiopulmonary bypass. A preliminary report. , 1993, Texas Heart Institute Journal.

[502]  S. Nicolson,et al.  Desmopressin does not decrease bleeding after cardiac operation in young children. , 1993, The Journal of thoracic and cardiovascular surgery.

[503]  M. Zimmerman,et al.  Hemorrhage After Coronary Artery Bypass Graft Procedures , 2003, Infection Control & Hospital Epidemiology.

[504]  O. V. Hein,et al.  Memory card: A tool to assess patient compliance with peritoneal dialysis. , 1999, Artificial Organs.

[505]  G. Wells,et al.  A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. , 1999, The New England journal of medicine.

[506]  S. Khuri,et al.  Effect of skin temperature on platelet function in patients undergoing extracorporeal bypass. , 1992, The Journal of thoracic and cardiovascular surgery.

[507]  E. Blackstone,et al.  Breaking down barriers: helpful breakthrough statistical methods you need to understand better. , 2001, The Journal of thoracic and cardiovascular surgery.

[508]  T. Ivert,et al.  Reoperations for bleeding after coronary artery bypass procedures during 25 years. , 1997, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[509]  F. Wisløff,et al.  Prolonged bleeding time with adequate platelet count in hospital patients. , 2009, Scandinavian Journal of Haematology.

[510]  K. Ward,et al.  Experimental analysis of critical oxygen delivery. , 2005, American journal of physiology. Heart and circulatory physiology.

[511]  S. Suvarna,et al.  A prospective randomised comparison of cardiotomy suction and cell saver for recycling shed blood during cardiac surgery. , 2003, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[512]  A. Dinopoulos,et al.  Neutrophil depletion reduces myocardial reperfusion morbidity. , 2004, The Annals of thoracic surgery.

[513]  S. Merrick,et al.  Use of recombinant factor VIIa as a rescue treatment for intractable bleeding following repeat aortic arch repair. , 2003, Annals of Thoracic Surgery.

[514]  Scher Ks.  Unplanned reoperation for bleeding. , 1996 .

[515]  M. Yoshikai,et al.  Clinical use of centrifugal pumps and the roller pump in open heart surgery: a comparative evaluation. , 1996, Artificial Organs.

[516]  S. Bélisle,et al.  Randomized, Placebo‐Controlled, Double‐Blind Study of an Ultra‐Low‐Dose Aprotinin Regimen in Reoperative and/or Complex Cardiac Operations , 1997, Journal of cardiac surgery.

[517]  C. Conti.  Management of patients with unstable angina. , 1980, Archivos del Instituto de Cardiologia de Mexico.

[518]  C. Deakin,et al.  Autotransfusion of washed shed mediastinal fluid decreases the requirement for autologous blood transfusion following cardiac surgery: a prospective randomized trial. , 1999, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[519]  R. Sade,et al.  A prospective randomized study of membrane versus bubble oxygenators in children. , 1980, The Annals of thoracic surgery.

[520]  R. Weiskopf.  Hemodilution and candles. , 2002, Anesthesiology.

[521]  T. Kazui,et al.  Role of biologic glue repair of proximal aortic dissection in the development of early and midterm redissection of the aortic root. , 2001, The Annals of thoracic surgery.

[522]  Jason Lee,et al.  Preoperative aspirin and heparin therapy does not increase perioperative blood loss and blood product requirements in coronary artery bypass graft surgery , 1999, Journal of Anesthesia.

[523]  A. Bengtsson,et al.  Coronary surgery without cardiotomy suction and autotransfusion reduces the postoperative systemic inflammatory response. , 2004, The Annals of thoracic surgery.

[524]  S. Body,et al.  Hematocrit value on intensive care unit entry influences the frequency of Q-wave myocardial infarction after coronary artery bypass grafting. The Institutions of the Multicenter Study of Perioperative Ischemia (McSPI) Research Group. , 1998, The Journal of thoracic and cardiovascular surgery.

[525]  P. Mongan,et al.  The role of desmopressin acetate in patients undergoing coronary artery bypass surgery. A controlled clinical trial with thromboelastographic risk stratification. , 1992, Anesthesiology.

[526]  H. Hashimoto,et al.  Expression and function of fibronectin binding integrins on rat mast cells. , 1995, International immunology.

[527]  D. Cosgrove,et al.  Failure of positive end-expiratory pressure to decrease postoperative bleeding after cardiac surgery. , 1982, The Annals of thoracic surgery.

[528]  M. DePerio,et al.  Thromboelastography-guided transfusion algorithm reduces transfusions in complex cardiac surgery. , 1999, Anesthesia and analgesia.

[529]  T. Menges,et al.  The role of the protein C-thrombomodulin system and fibrinolysis during cardiovascular surgery: influence of acute preoperative plasmapheresis. , 1996, Journal of cardiothoracic and vascular anesthesia.

[530]  V Gildengorin,et al.  Predictors of excessive blood use after coronary artery bypass grafting. A multivariate analysis. , 1989, The Journal of thoracic and cardiovascular surgery.

[531]  D. Tempe,et al.  Blood conservation in small adults undergoing valve surgery. , 1996, Journal of cardiothoracic and vascular anesthesia.

[532]  C. Ince,et al.  The effect of the transfusion of stored RBCs on intestinal microvascular oxygenation in the rat , 2001, Transfusion.

[533]  H. Ng,et al.  Successful control of postsurgical bleeding by recombinant factor VIIa in a renal failure patient given low molecular weight heparin and aspirin , 2003, Annals of Hematology.

[534]  D. Spodick.  Aortocoronary Bypass Surgery: Emerging Triumph of Controlled Clinical Trials , 1977 .

[535]  J. Jones,et al.  Effects of intraoperative plasmapheresis on blood loss in cardiac surgery. , 1990, The Annals of thoracic surgery.

[536]  R. Poses,et al.  Elective surgery without transfusion: influence of preoperative hemoglobin level and blood loss on mortality. , 1990, American journal of surgery.

[537]  V. Videm,et al.  Comparison of three oxygenator-coated and one total-circuit-coated extracorporeal devices , 1999, Perfusion.

[538]  H. Akintürk,et al.  Prolonged bleeding after cardiopulmonary bypass with recombinant hirudin in heart transplantation. , 1999, European Journal of Cardio-Thoracic Surgery.

[539]  D. Benckart,et al.  Repeated dose administration of desmopressin acetate in uncomplicated cardiac surgery: a prospective, blinded, randomized study. , 1992, Journal of cardiothoracic and vascular anesthesia.

[540]  S. Bélisle,et al.  Prophylactic Tranexamic Acid and ϵ-Aminocaproic Acid for Primary Myocardial Revascularization , 1998 .

[541]  D. Roberts,et al.  Factors influencing haemostasis and blood transfusion in cardiac surgery , 1996, Perfusion.

[542]  J. Linden,et al.  A report of 104 transfusion errors in New York State , 1992, Transfusion.

[543]  H. Aebert,et al.  The blood saving potential of vortex versus roller pump with and without aprotinin , 1995, Perfusion.

[544]  G. Despotis,et al.  Preoperative use of enoxaparin and tirofiban: possible association with increased bleeding postbypass. , 1999, Anesthesiology.

[545]  M. Yoshikai,et al.  Clinical Use of Centrifugal Pumps and the Roller Pump in Open Heart Surgery: A Comparative Evaluation. , 1996, Artificial organs.

[546]  G. Tenderich,et al.  Low dose systemic heparinization combined with heparin-coated extracorporeal circulation. Effects related to platelets. , 2001, The Journal of cardiovascular surgery.

[547]  D. Reich,et al.  Desmopressin acetate is a mild vasodilator that does not reduce blood loss in uncomplicated cardiac surgical procedures. , 1991, Journal of cardiothoracic and vascular anesthesia.

[548]  W. Reents,et al.  Influence of different autotransfusion devices on the quality of salvaged blood. , 1999, The Annals of thoracic surgery.

[549]  V. Fuster,et al.  Aspirin and other platelet-active drugs. The relationship between dose, effectiveness, and side effects. , 1992, Chest.

[550]  R. Weiskopf,et al.  Human cardiovascular and metabolic response to acute, severe isovolemic anemia. , 1998, JAMA.

[551]  R. Groom,et al.  Lowest hematocrit on bypass and adverse outcomes associated with coronary artery bypass grafting. Northern New England Cardiovascular Disease Study Group. , 2001, The Annals of thoracic surgery.

[552]  C. Kisker,et al.  Adequate anticoagulation during cardiopulmonary bypass determined by activated clotting time and the appearance of fibrin monomer. , 1978, The Annals of thoracic surgery.

[553]  W. Konertz,et al.  Use of desmopressin and erythropoietin in an anaemic Jehovah’s Witness patient with severely impaired coagulation capacity undergoing stentless aortic valve replacement , 2001, Perfusion.

[554]  B. Glenville,et al.  Air handling characteristics of five membrane oxygenators , 1994, Perfusion.

[555]  N. Laird,et al.  Perioperative red blood cell transfusion , 1988 .

[556]  M. Nakagawa,et al.  Bernard-Soulier syndrome associated with 22q11.2 microdeletion. , 2001, American journal of medical genetics.

[557]  N. Birkmeyer,et al.  Aprotinin in cardiac surgery. , 2006, New England Journal of Medicine.

[558]  R. C. Adams,et al.  Anesthesia in Cases of Poor Surgical RiskSome Suggestions for Decreasing the Risk , 1942 .

[559]  J. Monrigal,et al.  [Comparison of effects of aprotinin and tranexamic acid on blood loss in heart surgery]. , 1995, Annales Francaise d'Anesthesie et de Reanimation.

[560]  D. Green,et al.  The bleeding time as a preoperative screening test. , 1986, American Journal of Medicine.

[561]  W. Saggau,et al.  Blood-Air Interface during Cardiopulmonary Bypass , 2004, Asian cardiovascular & thoracic annals.

[562]  R. C. Dennis,et al.  Autologous blood transfusion during cardiopulmonary bypass. , 1976, Chest.

[563]  K. Engström,et al.  The inflammatory response to recycled pericardial suction blood and the influence of cell-saving , 2003, Scandinavian cardiovascular journal : SCJ.

[564]  J. Copeland,et al.  Aprotinin for primary coronary artery bypass grafting: a multicenter trial of three dose regimens. , 1996, The Annals of thoracic surgery.

[565]  A. Laupacis,et al.  Platelet-rich plasmapheresis in cardiac surgery: a meta-analysis of the effect on transfusion requirements. , 1998, The Journal of thoracic and cardiovascular surgery.

[566]  R. Martineau,et al.  A phase II dose-response study of hemoglobin raffimer (Hemolink) in elective coronary artery bypass surgery. , 2004, The Journal of thoracic and cardiovascular surgery.

[567]  M. Hosono,et al.  Use of heparin-coated cardiopulmonary bypass circuit with low-dose heparin reduces postoperative bleeding. , 1999, Annals of Thoracic and Cardiovascular Surgery.

[568]  M. Petitou,et al.  Structure-activity relationship in heparin: a synthetic pentasaccharide with high affinity for antithrombin III and eliciting high anti-factor Xa activity. , 1983, Biochemical and biophysical research communications.

[569]  A. Paterson,et al.  The association of biologically active lipids with the development of transfusion‐related acute lung injury: a retrospective study , 1997, Transfusion.

[570]  M. Kaplan,et al.  Cardiac operations for patients with chronic liver disease. , 2002, The heart surgery forum.

[571]  H. Nakatani,et al.  [Relation between intraoperative salvaged blood transfusion and postoperative infection after cardiac surgery]. , 2002, Kyobu geka. The Japanese journal of thoracic surgery.

[572]  W. van Oeveren,et al.  Heparin-coated circuits reduce the inflammatory response to cardiopulmonary bypass. , 1993, The Annals of thoracic surgery.

[573]  M. Spannagl,et al.  Influence of desmopressin acetate on homologous blood requirements in cardiac surgical patients pretreated with aspirin. , 1993, Journal of cardiothoracic and vascular anesthesia.

[574]  E. Lowenstein.  Blood conservation in open heart surgery. , 1981, Cleveland Clinic quarterly.

[575]  T. Inglis,et al.  Postoperative autologous transfusion in cardiac surgery. A prospective, randomised study. , 1990, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[576]  W. Dietrich,et al.  Reduction of blood utilization during myocardial revascularization. , 1989, The Journal of thoracic and cardiovascular surgery.

[577]  S. Bellucci,et al.  Molecular basis of Glanzmann's Thrombasthenia and current strategies in treatment. , 2002, Blood reviews.

[578]  W. Dietrich,et al.  Prevalence of anaphylactic reactions to aprotinin: analysis of two hundred forty-eight reexposures to aprotinin in heart operations. , 1997, The Journal of thoracic and cardiovascular surgery.

[579]  S. Büket,et al.  The effects of modified hemofiltration on inflammatory mediators and cardiac performance in coronary artery bypass grafting , 2000, Perfusion.

[580]  E. Stemmer,et al.  Erythrocyte survival following extracorporeal circulation. A question of membrane versus bubble oxygenator. , 1981, Journal of Thoracic and Cardiovascular Surgery.

[581]  Meyer Bj.  [Current approach in antithrombotic treatment during coronary interventions: specific thrombocyte aggregation inhibitors and direct thrombin antagonists in high-risk patients]. , 1996 .

[582]  Carl J Pepine,et al.  ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--2002: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients , 2002, Circulation.

[583]  R. Colman,et al.  Pericardial blood activates the extrinsic coagulation pathway during clinical cardiopulmonary bypass. , 1996, Circulation.

[584]  O. Dzemali,et al.  Leukocyte filtration fails to limit functional neutrophil activity during cardiac surgery , 2002, Inflammation Research.

[585]  M. Yoda,et al.  Autologous Blood Donation Before Elective Off-Pump Coronary Artery Bypass Grafting , 2003, Surgery Today.

[586]  J. Pepper,et al.  Recombinant human erythropoietin use in a critically ill Jehovah's witness after cardiac surgery. , 2005, Anesthesia and analgesia.

[587]  A. Spotnitz,et al.  Hemorrhage Related Reexploration following Open Heart Surgery: The Impact of Pre-Operative and Post-Operative Coagulation Testing , 2002, Cardiovascular surgery.

[588]  C. Baufreton,et al.  Clinical outcome after coronary surgery with heparin-coated extracorporeal circuits for cardiopulmonary bypass , 1996, Perfusion.

[589]  T. Ferguson,et al.  Blood conservation in cardiac surgery. Preliminary results with an institutional commitment. , 1989, Annals of surgery.

[590]  A. Bogers,et al.  Processing and transfusion of residual cardiopulmonary bypass volume: effects on haemostasis, complement activation, postoperative blood loss and transfusion volume , 2003, Perfusion.

[591]  W. Muntean,et al.  Inhibitor to factor V after exposure to fibrin sealant during cardiac surgery in a two‐year‐old child , 1994, Acta paediatrica.

[592]  W. Byerly,et al.  Effects of preoperative enoxaparin versus unfractionated heparin on bleeding indices in patients undergoing coronary artery bypass grafting. , 2003, The Annals of thoracic surgery.

[593]  J. Berlin,et al.  Effect of anaemia and cardiovascular disease on surgical mortality and morbidity , 1996, The Lancet.

[594]  C. Hogue,et al.  Effect of heparin on whole blood activated partial thromboplastin time using a portable, whole blood coagulation monitor. , 1995, Critical care medicine.

[595]  G. Bashein,et al.  Preoperative aspirin therapy and reoperation for bleeding after coronary artery bypass surgery. , 1991, Archives of internal medicine.

[596]  Y. Louvard,et al.  Implantation de prothèses endocoronaires sans antivitamine K. Résultats à un mois. , 1996 .

[597]  H. Schaff,et al.  Effect of Blood Conservation Efforts in Cardiac Operations at the Mayo Clinic , 1988 .

[598]  B. Reichart,et al.  Miniaturized cardiopulmonary bypass in coronary artery bypass surgery: marginal impact on inflammation and coagulation but loss of safety margins. , 2005, The Annals of thoracic surgery.

[599]  P. Mannucci,et al.  The Effect of Desmopressin on Reducing Blood Loss in Cardiac Surgery – A Meta-Analysis of Double-Blind, Placebo-Controlled Trials , 1995, Thrombosis and Haemostasis.

[600]  M. Turina,et al.  Reduction and elimination of systemic heparinization during cardiopulmonary bypass. , 1992, The Journal of thoracic and cardiovascular surgery.

[601]  S. Mierdl,et al.  Heparin Coating of the Extracorporeal Circuit Combined with Leukocyte Filtration Reduces Coagulation Activity, Blood Loss and Blood Product Substitution , 2001, The International journal of artificial organs.

[602]  T. Menges,et al.  The influence of acute preoperative plasmapheresis on coagulation tests, fibrinolysis, blood loss and transfusion requirements in cardiac surgery. , 1997, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[603]  H. Sadeghi,et al.  Tranexamic acid reduces blood loss and transfusion in reoperative cardiac surgery , 1997, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[604]  R. Ponlot,et al.  Haemostasis Disorders in Open Heart Surgery with Extracorporeal Circulation , 1977 .

[605]  T. Salerno,et al.  The cell saver during cardiac surgery: does it save? , 1982, The Annals of thoracic surgery.

[606]  Jubelirer Sj.  Coronary artery bypass in two patients with immune thrombocytopenic purpura without preoperative splenectomy. , 1992 .

[607]  D M Reboussin,et al.  Brain microemboli associated with cardiopulmonary bypass: a histologic and magnetic resonance imaging study. , 1995, The Annals of thoracic surgery.

[608]  S. Ferraris,et al.  Risk factors for postoperative morbidity. , 1996, Journal of Thoracic and Cardiovascular Surgery.

[609]  Keyvan Karkouti,et al.  La transfusion de plaquettes n’est pas associée à une hausse de la morbidité ou de la mortalité en cardiochirurgie , 2006 .

[610]  J. Gold,et al.  Intraoperative autologous blood donation preserves red cell mass but does not decrease postoperative bleeding. , 1996, Annals of Thoracic Surgery.

[611]  J. Hermans,et al.  Beneficial effects of leukocyte depletion of transfused blood on postoperative complications in patients undergoing cardiac surgery: a randomized clinical trial. , 1998, Circulation.

[612]  G. Hempelmann,et al.  Preoperative plasmapheresis in patients undergoing cardiac surgery procedures. , 1990, Anesthesiology.

[613]  E. Peterson,et al.  The Society of Thoracic Surgeons practice guideline series: aspirin and other antiplatelet agents during operative coronary revascularization (executive summary). , 2005, The Annals of thoracic surgery.

[614]  V. Ferraris,et al.  Mitral valve replacement in a patient with idiopathic thrombocytopenic purpura: preoperative treatment with danazol. , 1991, Journal of Cardiovascular Surgery.

[615]  M. Herbertson.  Recombinant activated factor VII in cardiac surgery , 2004, Blood Coagulation and Fibrinolysis.

[616]  Francesco Rodeghiero,et al.  Von Willebrand's disease in the year 2003: towards the complete identification of gene defects for correct diagnosis and treatment. , 2003, Haematologica.

[617]  N. Birkmeyer,et al.  To the editor [8] , 2006 .

[618]  H. Jumean,et al.  Monitoring of anticoagulant therapy during open-heart surgery in children with congenital heart disease. , 1983, Acta Haematologica.

[619]  T. Carrel,et al.  Elimination of proinflammatory cytokines in pediatric cardiac surgery: analysis of ultrafiltration method and filter type. , 2004, Journal of Thoracic and Cardiovascular Surgery.

[620]  W. Vaughn,et al.  Lowering the hemoglobin threshold for transfusion in coronary artery bypass procedures: effect on patient outcome , 1999, Transfusion.

[621]  A. Belboul,et al.  Improved blood cellular biocompatibility with heparin coated circuits during cardiopulmonary bypass. , 2000, The Journal of cardiovascular surgery.

[622]  W. Tsai,et al.  Leukocyte depletion attenuates expression of neutrophil adhesion molecules during cardiopulmonary bypass in human beings. , 2002, The Journal of thoracic and cardiovascular surgery.

[623]  J. Lemmer,et al.  Clinical experience in coronary bypass surgery for abciximab-treated patients. , 2000, The Annals of thoracic surgery.

[624]  R. Choussat,et al.  Vascular complications and clinical outcome after coronary angioplasty with platelet IIb/IIIa receptor blockade. Comparison of transradial vs transfemoral arterial access. , 2000, European heart journal.

[625]  C D Deakin,et al.  Reducing allogeneic transfusion in cardiac surgery: a randomized double-blind placebo-controlled trial of antifibrinolytic therapies used in addition to intra-operative cell salvage. , 2005, British journal of anaesthesia.

[626]  H. Lazarus,et al.  A prospective microbiologic surveillance program to detect and prevent the transfusion of bacterially contaminated platelets , 1993, Transfusion.

[627]  Raimondo Ascione,et al.  Early and midterm outcome after off-pump and on-pump surgery in Beating Heart Against Cardioplegic Arrest Studies (BHACAS 1 and 2): a pooled analysis of two randomised controlled trials , 2002, The Lancet.

[628]  S. Thein,et al.  A recurrent deletion in the antithrombin gene, AT106-108(-6 bp), identified by DNA heteroduplex detection. , 1993, Genomics.

[629]  M. Misfeld,et al.  Fibrinolysis-adjusted perioperative low-dose aprotinin reduces blood loss in bypass operations. , 1998, The Annals of thoracic surgery.

[630]  S. Thelin,et al.  Heparin-coated cardiopulmonary bypass circuits reduce blood cell trauma. Experiments in the pig. , 1991, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[631]  J. Pepper,et al.  A randomized comparison of off-pump and on-pump multivessel coronary-artery bypass surgery. , 2004, New England Journal of Medicine.

[632]  K. Kawazoe,et al.  Reduction of heparin dose is not beneficial to platelet function. , 2000, The Annals of thoracic surgery.

[633]  K. Jan,et al.  Effect of hematocrit variations on coronary hemodynamics and oxygen utilization. , 1977, The American journal of physiology.

[634]  E. Spitznagel,et al.  The impact of heparin concentration and activated clotting time monitoring on blood conservation. A prospective, randomized evaluation in patients undergoing cardiac operation. , 1995, The Journal of thoracic and cardiovascular surgery.

[635]  J. Thornby,et al.  Benefit from combining blood conservation measures in cardiac operations. , 1991, The Annals of thoracic surgery.

[636]  Wei Zhang,et al.  Continuous ultrafiltration attenuates the pulmonary injury that follows open heart surgery with cardiopulmonary bypass. , 2003, Annals of Thoracic Surgery.

[637]  G. Agnelli,et al.  Low-Molecular-Weight Heparins in the Management of Unstable Angina , 2000, Pathophysiology of Haemostasis and Thrombosis.

[638]  M. V. Van Dyck,et al.  Systematic use of aprotinin in cardiac surgery: influence on total homologous exposure and hospital cost. , 1992, Acta anaesthesiologica Belgica.

[639]  R. Mohr,et al.  The effect of transfusion of fresh whole blood versus platelet concentrates after cardiac operations. A scanning electron microscope study of platelet aggregation on extracellular matrix. , 1989, The Journal of thoracic and cardiovascular surgery.

[640]  P. Berguson,et al.  Blood transfusion requirements in coronary artery surgery with and without the activated clotting time (ACT) technique , 1985, Klinische Wochenschrift.

[641]  A. Jeppsson,et al.  Recombinant activated factor VII in the management of life-threatening bleeding in cardiac surgery. , 2005, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[642]  M M Cohen,et al.  A multivariable model for predicting the need for blood transfusion in patients undergoing first‐time elective coronary bypass graft surgery , 2001, Transfusion.

[643]  D. Loisance,et al.  Complement activation and use of a cell saver in cardiopulmonary bypass. , 1990, ASAIO transactions.

[644]  F. Boccara,et al.  [Thrombocytopenia after cardiac surgery due to anti-platelet allo-immunization. Apropos of a case]. , 1997, Archives des maladies du coeur et des vaisseaux.

[645]  A. Tortolani,et al.  Cardiopulmonary bypass in patients with pre-existing coagulopathy. , 2005, The journal of extra-corporeal technology.

[646]  H. Wendel,et al.  Gene Expression Changes in Leukocytes During Cardiopulmonary Bypass Are Dependent on Circuit Coating , 2005, Circulation.

[647]  D. Spahn,et al.  [Perioperative transfusion]. , 2006, Revue medicale suisse.

[648]  R. Groom,et al.  Intraoperative Red Blood Cell Transfusion During Coronary Artery Bypass Graft Surgery Increases the Risk of Postoperative Low-Output Heart Failure , 2006, Circulation.

[649]  E. Verrier,et al.  Infusion of autologous platelet rich plasma does not reduce blood loss and product use after coronary artery bypass. A prospective, randomized, blinded study. , 1993, The Journal of thoracic and cardiovascular surgery.

[650]  L. Hiratzka,et al.  Autologous Blood Transfusion in Elective Cardiac Valve Operations , 2005, Journal of cardiac surgery.

[651]  G. Wells,et al.  Does transfusion practice affect mortality in critically ill patients? Transfusion Requirements in Critical Care (TRICC) Investigators and the Canadian Critical Care Trials Group. , 1997, American journal of respiratory and critical care medicine.

[652]  Robert H. Jones,et al.  Intraoperative crossover: the well-kept surgical secret to apparent surgical success. , 2005, Journal of the American College of Cardiology.

[653]  E. Fosse,et al.  Differences in blood activation related to roller/centrifugal pumps and heparin coated/uncoated surfaces in a cardiopulmonary bypass model circuit , 1996, Perfusion.

[654]  P. Ribeiro,et al.  Results of Saphenous Vein Graft Stent Implantation: Single Center Results from Use of Oversized Balloon Catheters , 1999, Angiology.

[655]  R. Suojaranta-Ylinen,et al.  Recombinant factor VIIa in the treatment of postoperative hemorrhage after cardiac surgery. , 2005, The Annals of thoracic surgery.

[656]  L. Montenegro,et al.  Pro: the use of modified ultrafiltration during pediatric cardiac surgery is a benefit. , 1998, Journal of cardiothoracic and vascular anesthesia.

[657]  D. Cooley,et al.  Cardiovascular surgery in Jehovah's Witnesses. Report of 542 operations without blood transfusion. , 1977, JAMA.

[658]  L. Goodnough,et al.  The effect of an intraoperative treatment algorithm on physicians' transfusion practice in cardiac surgery , 1994, Transfusion.

[659]  Ü. Koçak,et al.  The effect of steroid and intravenous immunoglobulin on thrombopoietin levels in pediatric patients with immune thrombocytopenic purpura. , 2000, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[660]  R. Brand,et al.  Double-Blind, Randomized Controlled Trial on the Effect of Leukocyte-Depleted Erythrocyte Transfusions in Cardiac Valve Surgery , 2004, Circulation.

[661]  C. Tatooles,et al.  Aprotinin for coronary bypass operations: efficacy, safety, and influence on early saphenous vein graft patency. A multicenter, randomized, double-blind, placebo-controlled study. , 1994, The Journal of thoracic and cardiovascular surgery.

[662]  R. Shemin,et al.  Heparin-bonded circuits without a cardiotomy: a description of a minimally invasive technique of cardiopulmonary bypass , 2002, Perfusion.

[663]  M. Morice,et al.  [Coronary artery stenting without antivitamin K. Results after a month]. , 1996, Archives des maladies du coeur et des vaisseaux.

[664]  M. Hilgartner,et al.  CARDIAC SURGERY IN PATIENTS WITH PLASMA THROMBOPLASTIN ANTECEDENT (P.T.A.) DEFICIENCY. , 1965, The Journal of thoracic and cardiovascular surgery.

[665]  P. Castaldi,et al.  Cardiac-valve surgery in factor-VII deficiency. , 1968, The Lancet.

[666]  M. Johnston,et al.  Efficacy of intraoperative blood salvage during coronary artery bypass grafting. , 1997, Minerva Cardioangiologica : a Journal on Cardiovascular Pathophysiology, Clinical Medicine and Therapy.

[667]  J. Pincemail,et al.  Levels of inflammatory markers in the blood processed by autotransfusion devices during cardiac surgery associated with cardiopulmonary bypass circuit , 2002, Perfusion.

[668]  H. Meisner,et al.  Influence of combined zero-balanced and modified ultrafiltration on the systemic inflammatory response during coronary artery bypass grafting. , 1999, Journal of cardiothoracic and vascular anesthesia.

[669]  J. Civetta,et al.  Maintaining Quality of Care While Reducing Charges in the ICU Ten Ways , 1986 .

[670]  H. Stormorken,et al.  The value of activated coagulation time in monitoring heparin therapy during extracorporeal circulation. , 1984, Scandinavian journal of thoracic and cardiovascular surgery.

[671]  C. Osmer,et al.  Influence of different anticoagulation regimens on platelet function during cardiac surgery. , 1994, British journal of anaesthesia.

[672]  C. Dyke.  Safety of glycoprotein IIb-IIIa inhibitors: A heart surgeon's perspective. , 1999, American heart journal.

[673]  L. Goodnough,et al.  Blood conservation strategies to minimize allogeneic blood use in urologic surgery. , 1995, American journal of surgery.

[674]  G. Nuttall,et al.  Biocompatibility of Trillium Biopassive Surface-coated oxygenator versus uncoated oxygenator during cardiopulmonary bypass. , 2001, Journal of cardiothoracic and vascular anesthesia.

[675]  B. Kemkes,et al.  Urgent or Emergent Coronary Revascularization Using Bilateral Internal Thoracic Artery after Previous Clopidogrel Antiplatelet Therapy , 2003, The thoracic and cardiovascular surgeon.

[676]  M. Oppermann,et al.  Formation of C5a during cardiopulmonary bypass: inhibition by precoating with heparin. , 1991, The Annals of thoracic surgery.

[677]  A. Yazigi,et al.  Postoperative intravenous iron used alone or in combination with low-dose erythropoietin is not effective for correction of anemia after cardiac surgery. , 2004, Journal of cardiothoracic and vascular anesthesia.

[678]  W. Nugent.  Benchmarking cardiac surgery: a regional initiative to improve outcomes. Interview by Reggi Veatch. , 1994, The Quality Letter for Healthcare Leaders.

[679]  L. Goodnough,et al.  The Variability of Transfusion Practice in Coronary Artery Bypass Surgery , 1991 .

[680]  S. Kalaycioğlu,et al.  Evaluation of heparin-coated circuits with full heparin dose strategy. , 1999, Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia.

[681]  E. Jones,et al.  Effect of positive end-expiratory pressure on excessive mediastinal bleeding after cardiac operations. A controlled study. , 1983, The Journal of thoracic and cardiovascular surgery.

[682]  M. Petitou,et al.  Heparin degradation in the endothelial cells. , 1987, Thrombosis research.

[683]  J. Hirsh,et al.  Bleeding associated with antithrombotic therapy. , 1980, Seminars in hematology.

[684]  D. Drotar,et al.  Use of desmopressin acetate to reduce blood transfusion requirements during cardiac surgery in patients with acetylsalicylic-acid-induced platelet dysfunction. , 1994, Canadian journal of surgery. Journal canadien de chirurgie.

[685]  S. Body,et al.  Platelet transfusions during coronary artery bypass graft surgery are associated with serious adverse outcomes , 2004, Transfusion.

[686]  G. Tangen,et al.  Comparison of two heparin-coated extracorporeal circuits with reduced systemic anticoagulation in routine coronary artery bypass operations. , 2001, The Journal of thoracic and cardiovascular surgery.

[687]  K. Krieger,et al.  The Influence of Oxygenator Type and Priming Volume on Blood Requirements , 1998 .

[688]  M. Pöyhönen,et al.  Leucocyte content in blood processed by autotransfusion devices during open‐heart surgery , 1995, Acta anaesthesiologica Scandinavica.

[689]  J. Mahnken,et al.  Heparin-bonded cardiopulmonary bypass circuits reduce the rate of red blood cell transfusion during elective coronary artery bypass surgery. , 2005, Journal of cardiothoracic and vascular anesthesia.

[690]  M. Yazer,et al.  The effect of prestorage WBC reduction on the rates of febrile nonhemolytic transfusion reactions to platelet concentrates and RBC , 2004, Transfusion.

[691]  P. Grant,et al.  Ultra-low dose aprotinin decreases transfusion requirements and is cost effective in coronary operations. , 2001, The Annals of thoracic surgery.

[692]  D. Fergusson,et al.  Review of the clinical practice literature on patient characteristics associated with perioperative allogeneic red blood cell transfusion. , 2003, Transfusion medicine reviews.

[693]  S. Brister,et al.  Does the Use of Erythropoietin Reduce the Risk of Exposure to Allogeneic Blood Transfusion in Cardiac Surgery? A Systematic Review and Meta‐Analysis , 2006, Journal of cardiac surgery.

[694]  E. Raanani,et al.  Recombinant factor VIIa use in cardiac surgery--expanding the arsenal therapy for intractable bleeding? , 2004, Journal of Cardiovascular Surgery.

[695]  R. Califf,et al.  The anticoagulant therapy with bivalirudin to assist in the performance of percutaneous coronary intervention in patients with heparin-induced thrombocytopenia (ATBAT) study: main results. , 2003, The Journal of invasive cardiology.

[696]  R. Brunken,et al.  Coronary artery bypass in hereditary factor XI deficiency. , 1984, Annals of Thoracic Surgery.

[697]  C. Foroulis,et al.  A prospective, double-blind study on the efficacy of the bioline surface-heparinized extracorporeal perfusion circuit. , 2003, The Annals of thoracic surgery.

[698]  V. Ferraris,et al.  Comparison of blood reinfusion techniques used during coronary artery bypass grafting. , 1993, The Annals of thoracic surgery.

[699]  H. Huwer,et al.  Effects of high-dose aprotinin on renal function in aortocoronary bypass grafting. , 1995, The Annals of thoracic surgery.

[700]  C. Mueller-Eckhardt,et al.  POST‐TRANSFUSION PURPURA , 1986, British journal of haematology.

[701]  E. Picard,et al.  Aortic valve repair with fibrin glue for type A acute aortic dissection. , 1994, Annals of Thoracic Surgery.

[702]  T. Gourlay,et al.  Leucodepletion during cardiopulmonary bypass reduces blood transfusion and crystalloid requirements , 2001, Perfusion.

[703]  Thomas E. Moritz,et al.  Implications of preoperative administration of aspirin in patients undergoing coronary artery bypass grafting. Department of Veterans Affairs Cooperative Study on Antiplatelet Therapy. , 1990, Journal of the American College of Cardiology.

[704]  A. Cordell,et al.  An appraisal of blood salvage techniques in vascular and cardiac operations. , 1981, Annals of Thoracic Surgery.

[705]  S. Silvestry,et al.  Current status of cardiac surgery in the abciximab-treated patient. , 2000, The Annals of thoracic surgery.

[706]  K. Niwaya,et al.  Changes in platelet, granulocyte, and complement activation during cardiopulmonary bypass using heparin-coated equipment. , 1996, Artificial organs.

[707]  M. Cohen,et al.  Prospective comparison of hemorrhagic complications after treatment with enoxaparin versus unfractionated heparin for unstable angina pectoris or non-ST-segment elevation acute myocardial infarction. , 2001, The American journal of cardiology.

[708]  K. Niwaya,et al.  [Effect of blood conservation in open-heart surgery: a comparison of 3 different methods]. , 1994, Kyobu geka. The Japanese journal of thoracic surgery.

[709]  C. Bailey,et al.  Randomized placebo‐controlled double‐blind study of three aprotinin regimens in primary cardiac surgery , 1994, British Journal of Surgery.

[710]  J. Brockway,et al.  Neonatal pulse oximetry: accuracy and reliability. , 1989, Pediatrics.

[711]  E. Fosse,et al.  Disparity in blood activation by two different heparin-coated cardiopulmonary bypass systems. , 1995, The Annals of thoracic surgery.

[712]  A. Tobler,et al.  Fibrin glue in surgery: frequent development of inhibitors of bovine thrombin and human factor V , 1993, British journal of haematology.

[713]  T. Keys,et al.  The clinical usefulness of the preoperative bleeding time. , 1996, Archives of pathology & laboratory medicine.

[714]  L. Goodnough.  Experiences with recombinant human factor VIIa in patients with thrombocytopenia. , 2004, Seminars in hematology (Print).

[715]  C. Wong,et al.  Coagulation tests, blood loss, and transfusion requirements in platelet-rich plasmapheresed versus nonpheresed cardiac surgery patients. , 1994, Anesthesia and analgesia.

[716]  D. O'shaughnessy,et al.  Activated recombinant factor VII after cardiopulmonary bypass reduces allogeneic transfusion in complex non-coronary cardiac surgery: randomized double-blind placebo-controlled pilot study. , 2005, British journal of anaesthesia.

[717]  W. Tsai,et al.  Effect of leukocyte depletion on endothelial cell activation and transendothelial migration of leukocytes during cardiopulmonary bypass. , 2004, The Annals of thoracic surgery.

[718]  R. Pick,et al.  Evaluation of fibrin sealing for cardiovascular surgery. , 1984, Circulation.

[719]  G. Foulke,et al.  Effective measures for reducing blood loss from diagnostic laboratory tests in intensive care unit patients. , 1989, Critical care medicine.

[720]  M. Solomon,et al.  Cost comparison of intraoperative autologous versus homologous transfusion , 1988, Transfusion.

[721]  T. Yağdı,et al.  Desmopressin usage in elective cardiac surgery. , 2001, Journal of Cardiovascular Surgery.

[722]  W. Wagner,et al.  Heparin-coated cardiopulmonary bypass circuits: hemostatic alterations and postoperative blood loss. , 1994, The Annals of thoracic surgery.

[723]  Michael D. Brown.  Images in clinical medicine. Enterobius vermicularis. , 2006, New England Journal of Medicine.

[724]  L. Kumar,et al.  Letter: Candida diarrhoea. , 1976, The Lancet.

[725]  R. Bonato,et al.  Intraoperative plasmapheresis in cardiac surgery. , 1997, Journal of cardiothoracic and vascular anesthesia.

[726]  S. Ziemer,et al.  Caveat against the use of feiba in combination with recombinant factor viia. , 2003, The Journal of thoracic and cardiovascular surgery.

[727]  W. Saggau,et al.  Reduction of postoperative donor blood requirement by use of the cell separator. , 1985, Scandinavian journal of thoracic and cardiovascular surgery.

[728]  M. Al Douri,et al.  Effect of the administration of recombinant activated factor VII (rFVIIa; NovoSeven®) in the management of severe uncontrolled bleeding in patients undergoing heart valve replacement surgery , 2000, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[729]  E. Spitznagel,et al.  More Effective Suppression of Hemostatic System Activation in Patients Undergoing Cardiac Surgery by Heparin Dosing Based on Heparin Blood Concentrations rather than ACT , 1996, Thrombosis and Haemostasis.

[730]  J. Lazarchick,et al.  Impaired platelet function associated with parenteral nafcillin. , 1990, Annals of Clinical and Laboratory Science.

[731]  R. Haaverstad,et al.  Bleeding following Coronary Surgery after Preoperative Low-Molecular-Weight Heparin , 2004, Asian cardiovascular & thoracic annals.

[732]  A. Ramnath,et al.  No benefit of intraoperative whole blood sequestration and autotransfusion during coronary artery bypass grafting: results of a randomized clinical trial. , 2003, The Journal of thoracic and cardiovascular surgery.

[733]  S. Suzuki,et al.  Investigation of coronary artery bypass grafting for a patient with myelodysplastic syndrome. , 2001, Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia.

[734]  W. Saggau,et al.  Cell Saver, Ultrafiltration and Direct Transfusion: Comparative Study of Three Blood Processing Techniques , 2001, The Thoracic and cardiovascular surgeon.

[735]  C. Bodian,et al.  Predictors of transfusion requirements for cardiac surgical procedures at a blood conservation center. , 2004, The Annals of thoracic surgery.

[736]  D. W. Miller,et al.  Membrane versus bubble oxygenator for cardiac operations. A prospective randomized study. , 1980, The Journal of thoracic and cardiovascular surgery.

[737]  N. Smedira,et al.  Effectiveness of bivalirudin as a replacement for heparin during cardiopulmonary bypass in patients undergoing coronary artery bypass grafting. , 2004, The American journal of cardiology.

[738]  R. Robertazzi,et al.  Comparative study of biological glues: cryoprecipitate glue, two-component fibrin sealant, and "French" glue. , 1995, The Annals of thoracic surgery.

[739]  M. Borger,et al.  Off-pump coronary artery surgery for reducing mortality and morbidity: meta-analysis of randomized and observational studies. , 2005, Journal of the American College of Cardiology.

[740]  W. van Oeveren,et al.  Heparin coating of an extracorporeal circuit partly improves hemostasis after cardiopulmonary bypass. , 1994, The Journal of thoracic and cardiovascular surgery.

[741]  R. Weisel,et al.  Dipyridamole preserved platelets and reduced blood loss after cardiopulmonary bypass. , 1988, The Journal of thoracic and cardiovascular surgery.

[742]  M. Fox,et al.  Hard-shell cardiotomy reservoir for reinfusion of shed mediastinal blood. , 1989, The Annals of thoracic surgery.

[743]  G. Ruvolo,et al.  Changes in coagulation patterns, blood loss and blood use after cardiopulmonary bypass: aprotinin vs tranexamic acid vs epsilon aminocaproic acid. , 1996, The Journal of cardiovascular surgery.

[744]  E. Spitznagel,et al.  Use of point-of-care test in identification of patients who can benefit from desmopressin during cardiac surgery: a randomised controlled trial , 1999, The Lancet.

[745]  P. Mongan,et al.  Tranexamic Acid Is Effective in Decreasing Postoperative Bleeding and Transfusions in Primary Coronary Artery Bypass Operations: A Double-Blind, Randomized, Placebo-Controlled Trial , 1997, Anesthesia and Analgesia.

[746]  P. Brady,et al.  The use of ultra-low-dose aprotinin to reduce blood loss in cardiac surgery. , 1995, Journal of cardiothoracic and vascular anesthesia.

[747]  S. Bélisle,et al.  Low-dose aprotinin infusion is not clinically useful to reduce bleeding and transfusion of homologous blood products in high-risk cardiac surgical patients , 1993, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[748]  T. Ortel,et al.  Immunologic Impact and Clinical Outcomes After Surgical Exposure to Bovine Thrombin , 2001, Annals of surgery.

[749]  P. Berger,et al.  The thienopyridines. , 2002, Journal of interventional cardiology.

[750]  L. Stehling,et al.  Acute normovolemic hemodilution , 1991, Transfusion.

[751]  J. Klemperer,et al.  Combined aprotinin and erythropoietin use for blood conservation: results with Jehovah's Witnesses. , 1994, The Annals of thoracic surgery.

[752]  D. Monroe,et al.  Recombinant activated factor VII and the anaesthetist , 2005, Anaesthesia.

[753]  M. Pfisterer,et al.  Prevention of one-year vein-graft occlusion after aortocoronary- bypass surgery: a comparison of low-dose aspirin, low-dose aspirin plus dipyridamole, and oral anticoagulants , 1993, The Lancet.

[754]  D. Rubin,et al.  The central role of the propensity score in observational studies for causal effects , 1983 .

[755]  M. Avidan,et al.  Comparison of structured use of routine laboratory tests or near-patient assessment with clinical judgement in the management of bleeding after cardiac surgery. , 2004, British journal of anaesthesia.

[756]  T. Ryan,et al.  Reduced Protamine Dosage for Heparin Neutralization in Open‐Heart Operations , 1968, Circulation.

[757]  M. Endo,et al.  [Left ventricular free wall rupture]. , 2004, Kyobu geka. The Japanese journal of thoracic surgery.

[758]  A. Lefemine,et al.  Activated clotting time for control of anticoagulation during surgery. , 1985, The American surgeon.

[759]  T. Komiya,et al.  [Blood conservation effect and safety of shed mediastinal blood autotransfusion after cardiac surgery]. , 1998, The Japanese journal of thoracic and cardiovascular surgery : official publication of the Japanese Association for Thoracic Surgery = Nihon Kyobu Geka Gakkai zasshi.

[760]  R. Conroy,et al.  Heparin inhibition of von Willebrand factor-dependent platelet function in vitro and in vivo. , 1991, The Journal of clinical investigation.

[761]  I. Yada,et al.  Erythropoietin in pediatric cardiac surgery: clinical efficacy and effective dose. , 1997, Chest.

[762]  J. Wennberg,et al.  A regional prospective study of in-hospital mortality associated with coronary artery bypass grafting. The Northern New England Cardiovascular Disease Study Group. , 1991, JAMA.

[763]  A. Montoya,et al.  Immediate centrifugation of oxygenator contents after cardiopulmonary bypass. Role in maximum blood conservation. , 1978, The Journal of thoracic and cardiovascular surgery.

[764]  M. Debakey,et al.  Membrane vs Bubble Oxygenator: Clinical Comparsion , 1975, Annals of surgery.

[765]  S. Bélisle,et al.  Prophylactic tranexamic acid and epsilon-aminocaproic acid for primary myocardial revascularization. , 1998, The Annals of thoracic surgery.

[766]  R. Hongo,et al.  The effect of clopidogrel incombination with aspirin whengiven before coronary artery bypass grafting , 2002 .

[767]  R. Mammana,et al.  Autologous platelet-rich plasma in cardiac surgery: effect on intraoperative and postoperative transfusion requirements. , 1988, The Annals of thoracic surgery.

[768]  S. Coughlin,et al.  Desmopressin Acetate in Cardiac Surgery: A Double-Blind, Randomized Study , 1994, Southern medical journal.

[769]  M. Spannagl,et al.  Caveat against the use of activated recombinant factor VII for intractable bleeding in cardiac surgery. , 2002, Anesthesia and analgesia.

[770]  J. Andreasen,et al.  Prophylactic tranexamic acid in elective, primary coronary artery bypass surgery using cardiopulmonary bypass. , 2004, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[771]  D. Latter,et al.  Reinfusion of Mediastinal Blood in CABG Patients: Impact on Homologous Transfusions and Rate of Re‐exploration , 1996, Journal of cardiac surgery.

[772]  G. Gombos,et al.  Effects of a moderate-intensity aerobic program on blood viscosity, platelet aggregation and fibrinolytic balance in young and middle-aged sedentary subjects , 2004, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[773]  J. Wallis,et al.  Effect of WBC reduction of transfused RBCs on postoperative infection rates in cardiac surgery , 2002, Transfusion.

[774]  T. Preston.  Aortocoronary bypass surgery. , 1978, Chest.

[775]  Catherine Sudlow,et al.  Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients , 2002, BMJ : British Medical Journal.

[776]  Sunil V. Rao,et al.  The implications of blood transfusions for patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE National Quality Improvement Initiative. , 2005, Journal of the American College of Cardiology.

[777]  T. Utku,et al.  Chediak–Higashi syndrome in the intensive care unit , 2004, Paediatric anaesthesia.

[778]  R. Jordan,et al.  Abciximab Readministration: Results of the ReoPro Readministration Registry , 2001, Circulation.

[779]  Amy L. Seybert.  Bivalirudin Administration During Percutaneous Coronary Intervention: Emphasis on High‐Risk Patients , 2002, Pharmacotherapy.

[780]  D. Ph,et al.  The cardiac factor in stroke. , 1992 .

[781]  J. Obadia,et al.  Blood salvage in cardiac surgery. , 1991, Journal of cardiothoracic and vascular anesthesia.

[782]  W. Dietrich,et al.  Autologous blood donation in cardiac surgery: reduction of allogeneic blood transfusion and cost-effectiveness. , 2005, Journal of Cardiothoracic and Vascular Anesthesia.

[783]  A. Laupacis,et al.  Does Acute Normovolemic Hemodilution Reduce Perioperative Allogeneic Transfusion? A Meta-Analysis , 1998, Anesthesia and analgesia.

[784]  Y. Kikuchi,et al.  [Clinical evaluation of heparin concentration and activated clotting time monitoring (HEPCON HMS) system]. , 1997, [Zasshi] [Journal]. Nihon Kyobu Geka Gakkai.

[785]  V. Fuster,et al.  Aspirin and other platelet-active drugs. The relationship among dose, effectiveness, and side effects. , 1989, Chest.

[786]  T. David,et al.  Infective endocarditis in patients who had replacement of the aortic root. , 1994, Annals of Thoracic Surgery.

[787]  G. Schlag,et al.  Fibrin sealant, aprotinin, and immune response in children undergoing operations for congenital heart disease. , 1998, The Journal of thoracic and cardiovascular surgery.

[788]  A. Aggarwal,et al.  Recombinant activated factor VII (rFVIIa) as salvage treatment for intractable hemorrhage , 2004, Thrombosis journal.

[789]  R. Kekomäki,et al.  On‐site coagulation monitoring does not affect hemostatic outcome after cardiac surgery , 2001, Acta anaesthesiologica Scandinavica.

[790]  K. C. Anderson,et al.  Guidelines for transfusion support in patients undergoing coronary artery bypass grafting. Transfusion Practices Committee of the American Association of Blood Banks. , 1990, The Annals of thoracic surgery.

[791]  D. Schroeder,et al.  A comparison of bleeding and transfusion in patients who undergo coronary artery bypass grafting via sternotomy with and without cardiopulmonary bypass. , 2003, Journal of cardiothoracic and vascular anesthesia.

[792]  O. Alfieri,et al.  Impact of autologous blood predonation on a comprehensive blood conservation program. , 1995, The Annals of thoracic surgery.